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ABSTRACT
OLIGOPEPTIDE-FUNCTIONALIZED GRAFT COPOLYMERS: SYNTHESIS
AND APPLICATIONS IN NUCLEIC ACID DELIVERY
FEBRUARY 2009
REBECCA BOUDREAUX BREITENKAMP, B.S., UNIVERSITY OF SOUTHERN
MISSISSIPPI
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Todd S. Emrick
Utilizing the diverse functionality of amino acids, a new class of amphiphilic graft
copolymers has been synthesized, characterized, and explored for applications in
biomaterials and nucleic acid delivery. This thesis research focused on the syntheses of
oligopeptide-functionalized polyesters and polyolefins. Polyester functionalization was
geared towards applications in biomaterials, tissue engineering, and drug delivery by
incorporating sequences that promote cell-adhesion. These polyester-graft-oligopeptide
materials were prepared by a 1,3-Huisgen cycloaddition reaction, “click” chemistry, of an
azide-terminated oligopeptide (prepared by Fmoc-based solid phase peptide synthesis
(SPPS)) and alkyne-containing polyester (synthesized by ring-opening polymerization).
Following the syntheses of these materials, they were analyzed by nuclear magnetic
resonance (NMR) and organic gel permeation chromatography (GPC).
The oligopeptide-functionalized polyolefins were designed for nucleic acid
complexation, and therefore the oligopeptide sequences were intended to incorporate
positively-charged moieties (e.g., oligolysine) for DNA and short interfering RNA
(siRNA) complexation. These graft copolymers, prepared by SPPS followed by ring-
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opening metathesis polymerization, have highly tunable structures that enable control
over charge density and polymer backbone rigidity. Moreover, non-ionic hydrophilic
grafts such as polyethylene glycol were integrated into these polyelectrolytes such that
the charges along the polymer backbone are spaced accordingly while maintaining the
hydrophilicity of the polymer. While numerous applications for such charged, “biotailored” materials can be envisioned, this work is geared towards positively-charged
polyelectrolytes for their potential application in nucleic acid therapy, specifically the
delivery of plasmid DNA and siRNA. These graft copolymers were characterized (1H,
13

C NMR, organic and aqueous GPC), studied for their solution properties (static and

dynamic light scattering), and investigated as polyplexes with plasmid DNA.
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CHAPTER 1
INTRODUCTION

1.1 Introduction
Polymer materials are attractive candidates for many applications due to their
unique properties and tunability in terms of structure and function. Synthetic polymers
can be tailored for biological applications by controlling functionality, molecular weight,
degradation characteristics, and physical properties (Figure 1-1). Recognizing the value
of synthetic polymers as therapeutics and drug delivery vehicles, Ringsdorf and
coworkers pioneered the idea of polymer-based therapeutics over 30 years ago.1 Since
this time, this field has expanded to include such technology platforms as polymer drugs,2
polymer-drug conjugates,3-8 polymer micelles,9-11 and ionic multicomponent
polyplexes.12-16 In efforts to prepare polymers for specific areas such as biomaterials,
tissue engineering, and drug delivery, biologically-relevant moieties such as
oligopeptides,17-20 sugars,21-23 viruses,24 and drugs1 are often introduced as functional
initiators, end groups, or pendent side chains to enhance biocompatibility and water
solubility and enable targeted delivery for therapeutic applications (Figure 1-1). The
incorporation of therapeutic moieties in polymers presents synthetic and characterization
challenges as the physical properties of such conjugates are often atypical of traditional
polymer materials, requiring the use and development of techniques specific for each
type of therapeutic reagent or conjugate.
To date, linear polymers have been most utilized in polymer therapeutics due to
the relative ease of synthesis and characterization, ability to synthesize materials with low
polydispersity by controlled polymerization techniques, and the wide range of degradable

1

and non-degradable polymer backbones available. In addition to linear polymers,
branched polymers, graft or comb, and dendritic polymers can be used, and in many

Figure 1-1. Examples of polymer architecture and conjugation for therapeutics

cases are degradable. Despite the synthetic complexity associated with preparing
branched and dendritic polymers, they offer attractive attributes for polymer therapeutics

2

including the ability to introduce extensive and diverse functionality onto a single
polymer chain.
To exploit the unique attributes of polymer architecture, branched structures have
been prepared and studied as potential polymer-based therapeutics. For example, Stiriba,
Kautz, and Frey examined hyperbranched and linear polyglycerols, which have potential
for therapeutic delivery applications as nanocapsules.25 Unlike their linear analogs,
hyperbranched polyglycerols were able to encapsulate hydrophilic, small molecule dyes,
illustrating the benefit of macromolecular architecture for encapsulation/delivery
applications.
Dendritic macromolecules are perfectly-branched structures that have been
designed recently for in vivo applications such as drug delivery and magnetic resonance
imaging (MRI) contrast agents. During the early 1990’s, Newkome et al. synthesized
unimolecular micelles consisting of an amphiphilic dendrimer with a hydrophobic
interior and hydrophilic periphery.26 Due to the interior hydrophobic cavity, these
materials offered the potential to encapsulate hydrophobic, small-molecule drugs.
Fréchet and coworkers have also evaluated a variety of dendrimers and dendritic-like
macromolecules for applications in drug delivery. Taking advantage of the unique
structure and properties of dendrimers, degradable polyester-based systems,27 pHresponsive assemblies,28,29 dendrimer-drug conjugates,30 small molecule and protein drug
delivery agents,28,31-33 and targeted delivery systems30 have all been synthesized based on
these three-dimensional branched structures.
The use of dendrimers as MRI contrast agents has also been explored, beginning
with the work of Wiener, Tomalia, and coworkers.34 These contrast agents consist of

3

amine-functionalized PAMAM dendrimers conjugated to chelator moieties, enabling the
binding of gadolinium ions. The ability to attach numerous chelating moieties to the
dendrimer periphery is advantageous for imaging. Some dendrimer-metal chelate
conjugates bind up to 170 gadolinium ions, far exceeding the degree of functionalization
possible in linear polymer systems, where steric crowding limits the extent of chelation
possible.
While dendrimers offer promise for a variety of therapeutics, questions
concerning their cytotoxicity and scalability due to their multi-step synthesis have to date
limited their commercialization.35 In this thesis work, efforts are made to integrate the
advantages of branching through graft copolymer architectures, prepared by simple,
conventional polymerization methods. Specific graft copolymer targets include aliphatic
polyesters, which are hydrolytically degradable, and hydrophilic polyolefins, which are
hydrolytically stable. Both types of materials carry potential in therapeutic applications,
which will be introduced below and described specifically in subsequent chapters.

1.2 Polyesters for Therapeutics
The synthesis of polymers containing biologically active groups has been
undertaken with a variety of polymer structures including polyesters, polyanhydrides,
polyethers, and polymethyl(acrylates) as the backbone structure. Langer and coworkers
have studied degradable polymers as scaffolds for polymer-drug conjugates,36 delivery of
protein and DNA drugs,37-40 targeted therapeutics,19 and tissue engineering.19 Recently,
polymer-drug conjugates were prepared from commercially available dextran, a
biodegradable, biocompatible material, by its covalent conjugation to the chemotherapy
drug methoxtrexate. The polymer and drug were linked by an enzyme-specific
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oligopeptide sequence,36 Pro-Val-Gly-Leu-Ile-Gly, which is cleaved selectively by matrix
metalloproteinases, zinc-dependent enzymes found in elevated levels in cancerous tissue.
This design enables the site-specific enzymatic cleavage and release of the active drug. 36
These conjugates showed promise as an improved treatment method by offering
increased solubility and stability over the free drug and are currently under investigation
to determine in vivo stability and efficacy.
Other efforts in polymer therapeutics center on the development of biocompatible
polymer materials for tissue engineering applications.19,20,41 These systems utilize
degradable polymers that often incorporate oligopeptide sequences and hydrophilic
groups provide biocompatibility, water solubility, and receptor-ligand interactions. For
example, Hubbell and coworkers synthesized a cross-linked poly(ethylene glycol)-copoly(acrylic acid) network that was functionalized subsequently with RGD-containing
peptide sequences through the carboxylic acids in the poly(acrylic acid) block to promote
polymer-cell adhesion.41 In addition, Langer and coworkers have reported the pendent
functionalization of poly(lactic acid-co-lysine) with the adhesion-promoting sequence
RGD for material applications where cell growth is desired (e.g., tissue engineering).
This was accomplished by ring-opening polymerization of a lactone with a protected
lysine side chain, which was then deprotected to give free primary amines.19 The acid
terminus of the RGD-containing oligopeptide was coupled to this amine on the polyester
to generate pendent, oligopeptide functionality. Despite the progress this work
exemplified in the incorporation of oligopeptides into a hydrolytically degradable system,
problems encountered using this methodology included crosslinking, low peptide
incorporation (less than 1 mole percent), and polyester backbone degradation. Such

5

issues underscore the need for compatibility between the backbone structure and
functionalization conditions.

1.3 Polyolefins in Biomaterial Applications
Polyolefins such as polyethylene and polypropylene are classic commercial
plastics not often viewed as biologically relevant. However, polyolefins have been
explored in biological applications with their hydrolytically stable properties making
them suitable as implants and structured materials.42-44 Due to its functional group
tolerance,45,46 modern metathesis chemistry has enabled the synthesis of wide variety of
polyolefins including those with pendent carboxylate,47 ammonium,48 and oligopeptide4951

groups. For example, as shown in Figure 1-2, acyclic diene metathesis (ADMET) has

been used to incorporate single amino acids, peptide dimers, or trimers into unsaturated
hydrocarbon polymer backbones. Hopkins and Wagener described the integration of
various amino acids into these polyolefins using acyclic diene monomers and Grubbs’
Generation II catalyst. The resulting semi-crystalline material exhibited changes in its
melting temperature due to the incorporation of these amino acid moieties.49,52-54
Using ring-opening metathesis polymerization (ROMP), Grubbs, et al. prepared
polyethers with phenylalanine groups55 and poly(norbornene)s with bioactive moieties
such as GRGDS and PHSRN to synergistically inhibit cell binding to fibronectin-coated
surfaces to demonstrate the bioactivity of these oligopeptide-functionalized polymers.50,51
In the polynorbornene examples (Figure 1-2), a variety of monomers were prepared and
functionalized with individual amino acids or oligopeptide sequences and then
polymerized using Ru-based ROMP. Homopolymers of these monomers were prepared
as well as copolymers with short PEG chains. The resulting GRGDS and PHSRN
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materials were found to substantially reduce cell adhesion to fibronectin-coated surfaces
due to the ligand-based polymer-cell interactions, demonstrating the promise of ROMPderived materials for biological applications.

Figure 1-2. Application of metathesis techniques to synthesize bio-tailored
polyolefins

ROMP has also been used to incorporate other biomolecules, such as sugars, into
polyolefins. Grubbs and Fraser reported well-controlled, low polydispersity
polynorbornenes with two sugar groups per repeat unit, illustrating the functional group
tolerance of these ruthenium catalysts and enabling the synthesis of polyolefins with
highly-functional side chains.22 Kiessling and coworkers have also prepared saccharidecontaining polynorbornenes to prepare polyvalent scaffolds capable of protein
recognition.21,23 These polymers demonstrated both binding efficiency and recognition
specificity in their ligand interactions with the mannose/glucose-binding protein
concanavalin A, resulting in their potent inhibition of cell agglutination (i.e., the
aggregation of cells as a result of the protein agglutinin on the cell surface). The
multivalent nature of these polymers provides superior activity relative to the monovalent
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sugar derivatives. One polynorbornene-mannose derivative exhibited a 50,000-fold
increase in inhibitory activity.23

1.4 Polymers for Nucleic Acid Delivery
Synthetic, cationic polymers have emerged as reagents for complexation of
plasmid DNA (pDNA) and short interfering RNA (siRNA), termed polyplexes. Because
of the potential beneficial, medical impact of effective nucleic acid delivery, numerous
research labs have pursued this topic over the past 15-20 years.21 Science magazine’s
scientific breakthrough of 2002 was the RNA interference (RNAi) process, promoting
these small RNAs as having the potential to revolutionize modern medicine.56 RNAi is
the process by which short, single-stranded RNA (20-22 bases in length) binds messenger
RNA (mRNA) in the cytoplasm, marking the mRNA for destruction and therefore
preventing its protein expression. This process can be used to knockdown specific genes
to better determine their role or function in the cell. On the therapeutic side, small RNAs,
also known as short interfering RNA (siRNA), have been shown to shut down diseased
cells for cancer and HIV in vitro.57-59 Shortly after their discovery of the RNAi process,
Mello and Fire were awarded the 2006 Nobel Prize in Medicine. However, despite the
magnitude of the accomplishment, practical therapeutic applications for siRNA have
been slowed by ineffective delivery methods. Improving the delivery of these short
nucleic acids will enable progress toward clinical use of RNA treatments for cancer, HIV,
and other diseases. Indeed delivery is at the core of siRNA therapy and other nucleic
acid treatments, making it imperative the development of new materials that can safely
deliver these reagents to the desired in vivo target(s).
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An ideal nucleic acid delivery system would encapsulate the desired nucleic acid,
deliver it only to diseased cells, and efficiently express of the encapsulated nucleic acid
(in plasmid DNA therapy) or shutdown the complementary mRNA (in siRNA therapy)
while remaining non-immunogenic and non-cytotoxic throughout the body. While the
goal of gene therapy is to transport the genetic material to the nucleus where it can be
expressed, siRNA therapy focuses on the shutdown of diseased genes. The goal of
delivering siRNA is to transfect this 20-22 base pair oligonucleotide sequence to the
cell’s cytoplasm, where it will bind with complimentary mRNA, marking it for
destruction and preventing the mRNA from producing the undesired proteins associated
with the disease.60,61

Figure 1-3. Ideal nucleic acid delivery system

Currently, the primary approach to nucleic acid condensation and delivery uses
viral vectors. Genetically-modified viruses, such as adenoviruses and retroviruses,
provide excellent transfection efficiencies and subsequent gene expression. However,
serious safety issues, including the onset of leukemia-like symptoms and patient death in
clinical trials,62,63 have called into question the clinical viability of this approach. Nonviral approaches to gene therapy are gaining momentum especially using cationic
liposomes, small molecule and polymer-DNA conjugates, and polymer micelles for the
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condensation or packaging of genetic material. Despite their reduced transfection
abilities, non-viral systems exhibit fewer safety issues and can be better tailored for the
desired application. Synthetic polymers, in particular, offer modularity in synthetic
design with the ability to control molecular weight, polymer backbone, degradation
abilities, and incorporation of targeting moieties and other functionalities.
The complexation of DNA with cationic materials such as polylysine and
polyarginine have been studied for over 40 years.64,65 In 1995, Boussif and coworkers
first introduced poly(ethylene imine) (PEI), a common polymer for industrial
applications, as a cell transfection agent.66 PEI displays superior transfection efficiency
to other polymer-based systems and is considered to be state-of-the-art polymer
transfection reagent, available commercially under trade names such as JetPEI (PolyPlus
Transfection, Inc.). PEI’s excellent transfection efficiency is attributed to its ability to
effectively escape the endosome due to its proton sponge-like abilities of its backbone
secondary amines, i.e., the capability of the molecule to act as a reservoir for protons.
However, due to its cationic nature, PEI is cytotoxic.
While most research efforts focus on the modification of commercially-available
polymers to improve nucleic acid delivery, several research groups have designed
structurally-unique polymer transfection reagents (Figure 1-4), providing insight on the
structural parameters that facilitate effective cell transfection and DNA expression. The
design of synthetic polymers for effective and safe transfection can benefit from
consideration of both macromolecular architecture and functionality. DNA binding
affinity, ability to aid in endosomal escape, and biocompatibility are key features in
transfection that can be addressed by synthetic vectors. The binding affinity of DNA to
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cationic polymers is important as premature dissociation reduces cellular entry or leads to
nucleic acid degradation in the extracellular environment or in the endosome.
Kataoka and coworkers have designed an array of polymeric transfection reagents
over the past ten years with recent efforts based on functionalized PEG-block-poly(amino
acid) structures (Figure 1-4).12,14 In one example, thiol moieties were incorporated to
enable reversible crosslinking while controlling charge density.14 Such a system was
designed to create stable crosslinked structures, encapsulating and protecting pDNA
while circulating in vivo and later releasing DNA upon entry into the intracellular
cytoplasm. This release is triggered by the presence of excess glutathione, a reducing
agent found in large quantities in the cytoplasm as compared to other areas of the body.
These studies found that the polymers yielding the highest protein expression balanced
charge density and stability via disulfide crosslinking (i.e., if the degree of crosslinking
was too high, decreased protein expression was observed). The structure of the most
effective, environmentally-sensitive transfection reagent in these studies is shown in
Figure 1-4. The crosslinking also improved the shelf-stability of these materials, which
is important for commercial applications, and enabled the complexes to undergo freezethaw cycles without compromising their transfection abilities. However, these
polyplexes only exhibited moderate protein expression and would need structural
modifications to improve cell transfection and subsequent protein expression.
Kataoka et al. also prepared polymers with similar backbones for the
encapsulation and delivery of siRNA.12 As shown in Figure 1-4, the block copolymer
incorporated both primary and secondary amines into the side chains to allow ionic
complexation with the nucleic acid (primary amines) and to enhance the endosomal
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buffering capacity (secondary amines). These polycations were found to be more
effective than PEG-block-polylysine and comparable to RNAiFect, a commercial, lipidbased material from Qiagen, at knockdown of the targeted protein expression. However,
in contrast to RNAiFect, these materials were stable in the presence of serum, showing no
change in the subsequent knockdown efficiency, and still maintained greater than 75%
cell viability.

Figure 1-4. Polymer-based transfection agents for siRNA and/or pDNA delivery
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Reineke, Liu, and coworkers have focused on creating new polymer transfection
reagents by combining PEI-like segments with various biocompatible functionalities such
as saccharide moieties. In an effort to combine the effective cell transfection and
expression of PEI and the biocompatibility of chitosan, a new library of
poly(glycoamidoamine) materials (Figure 1-4) was synthesized with varying length
oligoamine segments and hydroxyl group stereochemistry.67,68 These polymers were able
to maintain the biocompatibility as reflected in high cell viability typical of chitosanbased reagents while, in some cases, also achieving high cell transfection relative to PEI.
It was also found that increased binding efficiency between the polycation and DNA,
which was correlated to the length of the oligoamine moiety in this case, resulted in more
effective cell transfection and DNA expression.
Building upon this work, the Reineke group recently used click chemistry to
synthesize poly(glycoamidoamine)s with higher molecular weights than obtained by
other condensation-based polymerization methods.69 Higher molecular weight polymers
have been shown to create more stable polyplexes with DNA and therefore are desirable
as polymeric transfection reagents.70-72 This synthetic methodology also allowed the
introduction of triazole groups, which like pyrrole or imidizole-containing polymers,73
bind with DNA in a specific manner (via hydrogen bonding to the DNA base pairs) to
increase complex stability. Other structural components were also included to enhance
this transfection reagent including trehalose groups, which are known to enhance
biocompatibility and prevent protein adsorption, and PEI-like oligoamine segments to
promote electrostatic binding to DNA and aid in endosomal escape. The resulting
polymers were found to be stable in water, serum, and salt, able to transfect cells in the
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presence and absence of serum, and maintain high cell viability with respect to the
commercial reagent JetPEI. By changing the polymer structure, it was found that the
properties of polycation-DNA complexes were governed by a combination of polymer
backbone stiffness, electrostatic interactions, and hydrogen bonding interactions.
However, these polymers still did not achieve protein expression levels as found in lipidbased, commercial transfection reagents such as Invitrogen’s Lipofectamine 2000.
Our research efforts focused on preparing novel, tailored polymers for various
biological applications based on a modular synthetic pathway. Amphiphilic graft
copolymers were chosen for this research for their tunability and the ability to incorporate
a wide range of functionality (e.g., oligopeptides, PEG, and reactive groups) into the
backbone. This modularity enables control over factors such as charge density,
hydrophilicity, and size, all of which are critical characteristics of polymers used in
nucleic acid delivery.

1.5 Research Outlook
This thesis research focused on the syntheses of oligopeptide-functionalized
polyesters and polyolefins (Figure 1-5). Polyester functionalization was geared towards
applications in biomaterials, tissue engineering, and drug delivery by incorporating
sequences that promote cell-adhesion (Chapter 2). These polyester-graft-oligopeptide
materials were prepared by a 1,3-Huisgen cycloaddition reaction, “click” chemistry, of an
azide-terminated oligopeptide (prepared by Fmoc-based solid phase peptide synthesis
(SPPS)) and alkyne-containing polyester (synthesized by ring-opening polymerization).
Following the syntheses of these materials, they were analyzed by nuclear magnetic
resonance (NMR) and organic gel permeation chromatography (GPC).
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Figure 1-5. Oligopeptide-functionalized polyesters and polyolefins for biomaterials
and nucleic acid delivery applications

The oligopeptide-functionalized polyolefins are described in Chapters 3 and 4.
These polymers were designed for nucleic acid complexation, and therefore the
oligopeptide sequences are intended to incorporate positively-charged moieties (e.g.,
oligolysine) for DNA and siRNA complexation. Due to the modularity of the synthetic
procedure, these polymers will also be explored as a new general class of polyelectrolyte
materials incorporating other charged amino acids into the polymer chain and observing
their solution properties (Chapter 3). SPPS was used to prepare the requisite
macromonomer, and ROMP was utilized to prepare these oligopeptide-functionalized
polymers. These graft copolymers were then characterized (1H, 13C NMR, organic and
aqueous GPC) and studied to determine their unique solution properties (static and
dynamic light scattering) and their potential as DNA delivery vectors.
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CHAPTER 2
OLIGOPEPTIDE-FUNCTIONALIZED POLYESTERS

2.1 Functionalization of Polyesters
Incorporating functional groups into aliphatic polyesters represents a synthetic
challenge due to the inherent hydrolytic sensitivity of esters. Commercially-available
aliphatic polyesters are not suited for all desired polyester applications, thus numerous
efforts have been made to modify their structure to enhance water-solubility and cell
targeting.1-3 Conditions for polyester functionalization must be carefully chosen to
prevent backbone degradation. Oligopeptide-incorporation into aliphatic polyester is
particularly difficult, as state-of-the-art oligopeptide synthesis uses coupling and
protection/deprotection conditions that are incompatible with the polyester backbone.
Another approach is to conjugate a deprotected oligopeptide with a functionalized
polyester. However, deprotection prior to coupling presents problems associated with
oligopeptide functionality (i.e., amines, alcohols, and carboxylic acids) that can interfere
with the intended grafting. In light of these problems, most attempts to decorate aliphatic
polyesters with peptide sequences have involved end-group functionalization or use of
functional initiators. To our knowledge, only one example of the synthesis of a
polyester-graft-oligopeptide was reported prior to this thesis research. This work was
from Langer and coworkers who polymerized a cyclic dimer of L-lactic acid and
protected L-lysine by ring-opening polymerization followed by deprotection of the
primary amines (Figure 2-1).1 The C-terminus of an RGD-containing oligopeptide was
then coupled to the pendent amine groups. Using this methodology, a small degree (less
than 1 mole percent) of oligopeptide incorporation was achieved, but problems such as
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crosslinking and backbone degradation were also encountered as would be expected from
the reaction of the two multifunctional reagents.

Figure 2-1. Synthesis of oligopeptide-functionalized polyesters by Langer and
coworkers

In order to address these issues, we wanted to examine whether the mild reaction
conditions associated with the Huisgen 1,3-dipolar cycloaddition of azides and alkynes,
an example of a “click” reaction, were applicable to aliphatic polyesters.4,5 Clickcycloaddition has recently gained popularity due to its high degree of specificity,
functional group tolerance, and ability to proceed in either aqueous or organic solvents.
This triazole formation is particularly attractive due to the ease with which these
functional groups can be introduced into small molecules and polymers. Sharpless,
Fokin, Finn, and coworkers have reported extensively on these reactions, and they along
with others have applied click chemistry to small molecules,4,5 virus particles,6 cell
membranes,7 dendrimers,8,9 and other polymers10 (Figure 2-2). In this research, the
question of whether click chemistry could be applied to polyesters and enable the
incorporation of oligopeptide sequences without polymer degradation was investigated.
21

Specifically, Cu(I)-catalyzed click chemistry was applied for grafting oligopeptides to
alkyne-functionalized aliphatic polyesters. This method enables the “bio-tailoring” of
aliphatic polyesters, structures already of interest in biomaterials research but potentially
enhanced for tissue engineering and drug delivery by attaching oligopeptides.

Figure 2-2. Synthesis and functionalization of materials using click chemistry
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2.2 Results and Discussion
Aliphatic polyesters containing pendent alkynes were prepared as shown in
Figure 2-3 by Bryan Parrish (Emrick Research Group, Ph.D. 2006).11 -Propargyl-valerolactone 1, synthesized from -valerolactone and propargyl bromide, was then
polymerized by Sn(OTf)2-mediated ring-opening polymerization. The alkyne-containing
lactone could be copolymerized with -caprolactone 2 or homopolymerized 3 in a
controlled fashion, yielding aliphatic polyesters with molecular weights typically ranging
from 6,000 – 16,000 g/mol with polydispersities between 1.1 – 1.2.

Figure 2-3. Synthesis of alkyne-functionalized polyesters
Due to its known cell binding properties,12,13 a RGD-containing sequence was
selected as the oligopeptide target. In this research, an azide-functionalized oligopeptide
4 was prepared by Fmoc-based solid phase peptide synthesis (Figure 2-4), starting from a
serine-loaded Wang resin and using the peptide coupling agent O-(Benzotriazol-1-yl)N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU).14 The oligopeptide
sequence was end-capped with 6-bromohexanoic acid under carbodiimide coupling
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conditions (DIC, HOBt, DMF) and cleaved from the resin with a 95:2.5:2.5 mixture of
TFA:water:triisopropylsilane (TIPS).15
In the published synthesis11, conversion of the oligopeptide-bromide to
oligopeptide-azide was carried out following cleavage from the resin. This was achieved
using excess sodium azide in DMSO at room temperature for three hours. The DMSO
was removed, and the oligopeptide was purified by precipitation and characterized by
NMR, IR, and mass spectrometry.
Some problems (e.g., residual DMSO) associated with this method led to a search
for improved conditions. An on-resin azide functionalization was tried following the
addition of 6-bromohexanoic acid and prior to resin cleavage. Excess NaN3 in 85:15
DMF:MeOH was added to the resin, and the mixture was agitated for three hours. After
this time period, it was found that the bromide to azide conversion went only to 75%
completion based on 1H NMR spectroscopy (Br -protons – triplet at 3.52 ppm, N3 protons – triplet at 3.32 ppm). Therefore, the resin was filtered, and fresh NaN3 solution
was added to the resin. After three hours of agitation, complete conversion to the desired
azide group was observed by NMR. The SDGRG-N3 5 sequence was then deprotected
and cleaved from the resin with 95:2.5:2.5 TFA:water:TIPS and purified by precipitation
in diethyl ether. The desired compound was isolated as a white solid in 99% yield (based
on resin loading) and characterized by 1H and 13C NMR, IR, and low and high resolution
mass spectrometry, all of which supported the desired structure. High resolution mass
spectrometry (HRMS-FAB) yielded a major [M+H]+ peak at 630.296, the exact value of
the calculated mass, and the diagnostic azide stretch was observed by IR at 2097 cm-1.
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Figure 2-4. Two methods for the Fmoc-based solid phase peptide synthesis of
SDGRG-azide 5

After synthesizing both the alkyne-containing polyesters 2 and 3 and azidecapped oligopeptide 5, the Cu(I)-catalyzed click reaction was used to prepare the desired
oligopeptide-functionalized polyester (Figure 2-5).11 Initial attempts to synthesize
aliphatic polyester-graft-oligopeptides were carried out on the alkyne-functionalized
homopolymer 3 to give 5 mole percent peptide grafting. To achieve this, compound 5
(0.05 eq) was dissolved in water, and an acetone solution of the alkyne-polyester
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homopolymer 3 (1.0 eq) was added drop wise to the aqueous, rapidly stirring, peptide
solution. Copper sulfate pentahydrate (0.4 eq) and sodium ascorbate (0.8 eq) were
introduced into the solution, and the mixture was heated to 100 ºC for three hours and
stirred overnight at 80 ºC. The solution was cooled to room temperature and diluted with
an aqueous saturated NaCl solution. The product was extracted with methylene chloride,
dried over magnesium sulfate, and concentrated on a rotary evaporator.

Figure 2-5. Synthesis of oligopeptide-grafted polyester by click chemistry

The peptide-functionalized polyester 6 obtained in this fashion was characterized
by 1H NMR spectroscopy and GPC (Figure 2-6). The success of the reaction was
confirmed by the presence of signals in the 1H NMR spectrum from  6.70-7.80 ppm,
corresponding to the peptide amides and triazole. It should be noted that the azideterminated SDGRG oligopeptide is not soluble in chloroform, and if physically mixed
with the starting polyester, its proton signals were not observed in 1H NMR spectroscopy
in CDCl3. The presence of signals in the amide region of the 1H spectrum provides
evidence for the covalent attachment of the oligopeptides to the polyester backbone.
To further support peptide grafting and investigate the integrity of the polyester
backbone over time, GPC characterization in DMF was performed on the resulting
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materials. GPC characterization of the peptide-functionalized product (Figure 2-6)
changed only slightly from the starting material as expected for such a low grafting
density. It is apparent from the GPC traces that no substantial crosslinking or
degradation of the polyester occurred during the course of the reaction. Moreover, it
appears that these polyesters are shelf stable. The weak signal at low retention time (high
molecular weight) in the GPC trace is attributed to possible aggregation of the
oligopeptide-functionalized aliphatic polyester in the eluent (DMF).

Figure 2-6. GPC characterization of the starting polyester 3 (left) and the polyestergraft-oligopeptide 6 (right) after the click reaction

In summary, a new synthesis has been presented in which aliphatic polyesters are
functionalized with oligopeptides. The synthesis relies on polymerization of alkynefunctionalized lactones and subsequent grafting using click cycloaddition of azideterminated oligopeptides. This approach represents a convenient, rapid, and versatile
synthesis of functionalized aliphatic polyesters, in which the mild conditions associated
with click chemistry allow for post-polymerization functionalization in the absence of
polyester degradation. It is anticipated that the structural and functional variation
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obtained by the methods outlined here will useful in several areas, including biomaterials
and various encapsulation and delivery technologies.

2.3 Future Research
Future efforts on the optimization of the reaction conditions with respect to
temperature and catalyst selection could provide valuable insight of the scope of this
click methodology for polyesters. It was postulated that the high reaction temperature
(100 ºC) needed for cycloaddition onto polyester backbone (many click reactions proceed
rapidly at room temperature) was due to binding of the copper to the wide range of
functionality in the oligopeptide side chains. In fact, binding of Cu(II) with peptide
amides has been reported16 and may be the reason higher temperatures were required.
Different copper-based catalyst systems have been developed for the optimization of
click chemistry and involve the addition of various ligands and reducing agents. One
useful system employs copper sulfate in conjunction with the ligand
bathocuproinedisulphonic acid disodium salt hydrate and the reducing agent tris(2carboxyethyl)phosphine hydrochloride.17,18 The system may reduce Cu(II)-peptide
interactions due to ligand binding and facilitate the click reaction of the SDGRG
sequence at lower temperatures.
Demonstrating versatility with respect to percent peptide incorporation and the
oligopeptide sequence would also being interesting in further studies. Initial efforts
focused on incorporating only five mole percent oligopeptide so as to maintain the
organic solubility of the polymer and facilitate isolation and characterization. However,
higher levels of oligopeptide may be desirable in certain applications. Also,
demonstrating versatility of this methodology in terms of the selected oligopeptide
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sequence is important. Many azide-terminated oligopeptides are in principle suitable for
click chemistry. One proposed study would focus on clicking cationic oligopeptides to
aliphatic polyesters for applications in nucleic acid encapsulation and delivery. While the
polyolefin-graft-pentalysine system offers a hydrolytically stable, robust backbone that
can be used to encapsulate plasmid DNA as discussed in Chapters 3-4, a polyester-graftpentalysine (or other cationic amino acid) generates a polymeric encapsulation system
that is degradable. Azide-functionalized pentalysine and pentaarginine sequences have
been prepared by solid phase peptide synthesis as previously described for SDGRG. In a
similar approach to the polyolefin system described in Chapters 3-4, variations in the
polymer structure could be explored for such applications including the incorporation of
other cationic sequences (lysine versus arginine) and PEG groups in conjunction with the
peptide grafts.

2.4 Experimental Section
2.4.1 Materials
1-hydroxybenzotriazole (HOBt) (<5% water), piperidine (99+%), N,N'diisopropylcarbodiimide (DIC) (99%), 2,2,2-trifluoroethanol (TFE) (99.5%), 6bromohexanoic acid (98%), sodium azide (99.5%), TIPS (99%), and phenol (99+%) were
purchased from Sigma Aldrich (Saint Louis, MO). N,N-diisopropylethylamine (DIPEA)
(99%) was obtained from Alfa Aesar (West Chester, PA). Copper (II) sulfate
pentahydrate (ACS reagent grade) and TFA (reagent grade) were purchased from Thermo
Fisher Scientific Inc. (Waltham, MA). Fmoc-Gly-OH, Fmoc-Ser(But)-OH, FmocAsp(OBut)-OH, Fmoc-Arg(Pbf)-OH, HBTU, and Fmoc-Ser(But)-loaded Wang resin
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(100-200 mesh, loading density of 0.6 mmol/g) were purchased from Advanced
ChemTech (Louisville, KY). Deuterated solvents CDCl3 and D2O were obtained from
Cambridge Isotopes (Andover, MA). Sodium ascorbate (crystalline) was purchased from
Source Naturals. CH2Cl2 was washed according to standard procedures35 and distilled
over CaH2. All other materials were used without additional purification. 

2.4.2 Instrumentation
NMR spectra were recorded in CDCl3, d6-DMSO, or D2O solutions using a
Brüker DPX300, Brüker Avance400, or Brüker Avance600 spectrometer (w13C =
0.25*w1H). Molecular weights and polydispersity indices were measured by gel
permeation chromatography in DMF relative to polystyrene standards (Scientific
Polymer Products Mp= 503, 700, 1306, 2300, 4760, 12,400, 196,700 and 556,000 g/mol)
on systems equipped with three-column sets (Polymer Laboratories 300 x 7.5 mm, 5 mm,
10-5, 10-4, and 10-3 Å pore sizes) and refractive-index detectors (HP 1047A) at room
temperature (THF) and 50 ˚C (DMF) with a flow rate of 1 mL/min. High resolution mass
spectral (HRMS) data were obtained on a JEOL JMS700 MStation. IR absorbance data
was obtained on a Perkin Elmer Spectrum One FT-IR spectrometer equipped with a
universal ATR sampling accessory.
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2.4.3 Synthesis of -Propargyl--valerolactone (1)

n-Butyllithium (42.5 mL, 93.5 mmol) was added by syringe to a solution of N,Ndiisopropylamine (13.1 mL, 93.5 mmol) in 625 mL THF at -78 ˚C and stirred for 15
minutes. A solution of -valerolactone (8.51 g, 85.0 mmol) in 225 mL THF was added
drop wise over 1.5 hours and then stirred for an additional 30 minutes. Propargyl
bromide (11.4 mL, 102 mmol) and hexamethylphosphoramide (17.7 mL, 102 mmol)
were added drop wise over 20 minutes. The reaction mixture was then warmed to
approximately -30 °C, and the temperature was maintained while stirring for two hours.
Excess aqueous ammonium chloride was added, and the reaction mixture was allowed to
warm to room temperature. Volatiles were removed by rotary evaporation. The resulting
product was dissolved in ether, washed with a saturated NaCl aqueous solution, diluted
with hexanes, washed again with the NaCl solution, dried over MgSO4, and concentrated.
Column chromatography (gradient 0-30% EtOAc in hexanes) on silica gel followed by
Kugelrohr distillation afforded 1 as a colorless, viscous liquid (8.68 g, 74% yield).
HRMS-EI (m/z): [M+H]+ calculated for C8H11O2 139.076, found 139.078. 1H NMR
(CDCl3, 300 MHz): d (CHCl3 = 7.26 ppm) 4.28 (m, 2H, CH2O), 2.62 (m, 2H,
COCHCH2), 2.46 (m, 1H, COCHCH2), 2.22 (sxt, J = 6.4 Hz, 1H, CHCH2CH2), 1.97 (t-d,
J = 2.7 Hz J = 1.0 Hz, 1H, CCH), 1.89 (q, J = 6.3 Hz, 2H, CH2CH2CH2), 1.68 (m, 1H,
COCHCH2) ppm.

13

C NMR (CDCl3, 75 MHz): d (CHCl3 = 77.0 ppm) 172.8 (C=O),

81.1 (CCH), 70.4 (CH2O), 68.8 (CHC), 38.9 (CC=O), 24.1 (CCH2CH2), 22.0
(CCH2CH2), 20.7 (CH2CCH) ppm. IR(ATR): CC-H 3280, C=O 1724 cm-1.
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2.4.4 Representative Polymerization - Synthesis of (2)

Lactone 1 and -caprolactone were distilled over CaH2. Glass reaction vessels
were flame-dried three times under a stream of N2(g). EtOH (110 mL, 1.7 M solution in
THF) and Sn(OTf)2 (150 mL, 3.7 x 10-2 M solution in THF) were introduced to the
reaction vessel and allowed to stir for 15 minutes. Compound 1 (1.10 g, 8.0 mmol) and
-caprolactone (0.91 g, 8.0 mmol) were then added to the vessel by syringe. The mixture
was stirred at room temperature for 48 hours and then dissolved in acetone and
precipitated into cold hexanes. Residual 1 was removed by passage through a plug of
silica gel, eluting with 50:50 EtOAc:hexanes followed by elution of the product with
acetone. Solvent was removed by rotary evaporation to give pure polymer 2 as a clear
viscous liquid (1.83 g, 91%). GPC (THF): Mn = 7.5 x 103 g/mol, PDI = 1.11. 1H NMR
(CDCl3, 300 MHz):  (CHCl3 = 7.26 ppm) 4.07 (m, 4H, CH2OPVL+CL), 2.58 (m, 1H,
C=OCHPVL), 2.45 (m, 2H, CH2CCHPVL), 2.29 (tr, J = 7.3 Hz, 2H, C=OCH2CL), 2.03 (m,
1H, CCHPVL), 1.64 (br m, 8H, CH2CH2CH2OPVL + CH2CH2CH2CH2OCL), 1.39 (br m,
2H, CH2CH2CH2OCL) ppm.

13

C NMR (CDCl3, 75 MHz):  (CHCl3 = 77.0 ppm) 174.1

(C=OPVL), 173.6 (C=OCL), 81.1 (CCHPVL), 70.2 (CCHPVL), 64.6 (CH2OPVL), 64.2
(CH2OCL), 44.0 (C=OCHPVL), 34.2 (C=OCH2CL), 28.4 (CH2CH2OCL), 27.6 (CHCH2PVL),
26.2 (CHCH2CH2PVL), 25.6 (C=OCH2CH2CH2CL), 24.6 (C=OCH2CH2CL), 21.3
(CH2CCHPVL) ppm. IR(ATR): CC-H 3283, C=O 1726 cm-1.
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2.4.5 Synthesis of Azide-terminated SDGRG (5) from Bromide-terminated SDGRG
(4) using Method 1

The oligopeptide sequence SDGRG was synthesized according to standard Fmoc
solid phase peptide synthesis using the batch wise process and the peptide coupling agent
HBTU. Fmoc-Ser(But)-loaded Wang resin (3.12 g with loading density of 0.6 mmol/g)
was weighed into an oven-dried glass-fritted reaction tube and swollen with 30 mL dry
CH2Cl2 for 5-10 minutes. The Fmoc group at the N-terminus was cleaved by the addition
of a 25/75 solution of piperidine/DMF (30 mL), followed by agitation with nitrogen for
three minutes. The resin was filtered, and fresh piperidine/DMF (30 mL) was added.
After agitating for 20 minutes, the resin was filtered and washed with DMF six times.
A solution of Fmoc-Asp(OBut)-OH (3.85 g, 9.35 mmol), HBTU (3.48 g, 9.17
mmol), and HOBt (1.26 g, 9.35 mmol) in 20 mL of anhydrous DMF was prepared. After
the solution became homogeneous, DIPEA (3.28 mL, 18.70 mmol) was added, and the
resulting mixture was added immediately to the resin. The resin was then agitated for
one hour, filtered, and washed with DMF (three times). A 25/75 solution of
piperidine/DMF (30 mL) was added, and the resin agitated for three minutes. After
filtration, piperidine/DMF was again added to the resin followed by agitation for 20
minutes. The resin was then washed with DMF (six times). The above amino acid
addition procedure was repeated for Fmoc-Gly-OH, Fmoc-Arg(Pbf)-OH, and a second
unit of Fmoc-Gly-OH.
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Following the addition of the second Gly unit, a solution of 6-bromohexanoic acid
(1.82 g, 9.35 mmol) and HOBt (1.26 g, 9.35 mmol) was prepared in 15 mL of dry DMF.
DIC (1.45 mL, 9.35 mmol) was added drop wise to the solution and stirred for 20
minutes. The activated solution was added to the resin and agitated for one hour. After
filtration, the resin was washed with DMF (six times) followed by CH2Cl2 (four times) to
remove any residual DMF.
Two different approaches were then used to prepare the final azide-functionalized
SDGRG 5. Initial efforts cleaved the peptide from the resin after this coupling reaction
whereas latter studies streamlined the synthesis by introducing the azide-functionality
prior to resin cleavage. To generate the material by the first method, the peptide was
deprotected and cleaved from the resin by agitating with a 95/2.5/2.5 solution of
TFA/H2O/TIPS (30 mL) for three hours. The solution was filtered, and the cleavage
procedure was repeated with 30 mL of fresh solution and 30 minutes of agitation. The
resin was then washed with CH2Cl2 (three times), and the filtrate was concentrated by
rotary evaporation, precipitated into diethyl ether, and stored at 4 ºC for several hours
before filtration. The solid was isolated by filtration, rinsed with diethyl ether (three
times), and dried under vacuum overnight to afford the Br-terminated oligopeptide 4 as a
white powder in nearly quantitative yield (based upon the given resin-loading density).
HRMS-FAB (m/z): [M+H]+ calculated for C23H39N8O10Br 667.205, found 667.207. 1H
NMR (d6-DMSO, 400 MHz):  (DMSO = 2.50 ppm) 11.90 (br, 2H), 8.30 (br, 1H), 8.20
(d, J = 7.9 Hz, 1H), 8.07 (m, 2H), 7.88 (d, J = 7.7 Hz, 1H), 7.72 (br, 1H), 7.16 (br, 2H),
4.64 (m, 1H), 4.22 (m, 2H), 3.66 (m, 8 H), 3.50 (tr, J = 6.7 Hz, 2H), 3.07 (m, 2H), 2.13
(tr, J = 7.2 Hz, 2H), 1.78 (m, 2H), 1.64 (br, 2H), 1.50 (m, 6H), 1.35 (m, 2H) ppm.
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13

C

NMR (d6-DMSO, 100 MHz):  (DMSO = 39.52 ppm) 172.7, 172.0, 171.9, 170.7, 169.4,
168.7, 156.8, 61.4, 55.0, 52.3, 49.4, 42.1, 40.4, 36.4, 35.1, 35.0, 32.1, 29.1, 27.3, 24.9,
24.4 ppm. ATR-FTIR: O-H and N-H 3286.1, C-H 2937.0, C=O 1644.1, N-H 1531.9
cm-1.
Bromide-terminated SDGRG 4 (1.17 g, 1.75 mmol) was dissolved in DMSO (3.5
mL, 0.5 M), and NaN3 (0.13 g, 2.00 mmol) was added to the solution. The reaction was
allowed to proceed for 12-18 hours at room temperature after which the solution was
filtered through Celite. Following rotary evaporation and Kugelrohr distillation to
remove the DMSO, the crude product was dissolved in a minimal amount of methanol,
and the residual salts were removed by filtration. The remaining solution was
precipitated from diethyl ether and filtered to afford the azide-terminated sequence 5 as a
white powder (1.09 g, 99% yield). HRMS-FAB (m/z): [M+H]+ calculated for
C23H39N11O10 630.296, found 630.296. 1H NMR (d6-DMSO, 400 MHz):  (DMSO =
2.50 ppm) 8.36 (br, 1H), 8.27 (m, 2H), 8.07 (m, 2H), 7.72 (d, J = 7.4 Hz, 1H), 7.23 (br,
2H), 4.58 (m, 1H), 4.23 (m, 1H), 4.14 (m, 1H), 3.59 (m, 8H), 3.29 (tr, J = 6.8 Hz, 2H),
3.07 (m, 2H), 2.13 (tr, J = 7.3 Hz, 2H), 1.76 (m, 2H), 1.50 (m, 6H), 1.28 (m, 2H) ppm.
13

C NMR (d6-DMSO, 100 MHz):  (DMSO = 39.52 ppm) 173.4, 172.7, 172.6, 172.4,

170.6, 169.3, 168.8, 157.2, 61.8, 55.3, 52.4, 50.6, 49.7, 42.5, 42.0, 40.5, 36.8, 35.0, 29.4,
28.1, 25.8, 24.7, 24.5 ppm. ATR-FTIR: O-H and N-H 3261, N=N=N 2097, C=O 1645
cm-1.
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2.4.6 Synthesis of Azide-terminated SDGRG (5) using Method 2

The second method for preparing the azide-functionalized SDGRG 5 followed the
same methodology as the first approach until the resin cleavage. Following the addition
of 6-bromohexamoic acid and prior to resin cleavage as previously described, a solution
of NaN3 (0.61 g, 9.35 mmol) in 85/15 DMF/MeOH was added to the resin and agitated
for three hours. The solution was filtered, and a fresh NaN3 solution was added to the
resin and agitated for another three hours. After filtering the solution from the resin, the
resin was washed with 85/15 DMF/MeOH several times to remove residual NaN3 and
then DCM to wash away the residual DMF. The oligopeptide was then cleaved by
agitating the resin with 95/2.5/2.5 TFA/H2O/TIPS (30 mL) for three hours. The filtrated
was collected in a clean flask, and the resin was washed with fresh cleavage solution and
DCM several times. The solution was concentrated on a rotary evaporator and dissolved
in minimal MeOH. The oligopeptide was precipitated from diethyl ether and isolated by
filtration. The resulting white solid was isolated in 99% yield. Characterization of the
resulting materials agreed with the data previously collected by 1H and 13C NMR,
HRMS, and ATR-FTIR.
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2.4.7 Click Reaction Conditions for Polyester-graft-SDGRG (6)

Azide-terminated SDGRG 5 (23 mg, 0.036 mmol) was dissolved in 2 mL of water
and heated to 80 ˚C. The acetylene-functionalized homopolymer 3 (100 mg, 0.72 mmol
acetylene) was dissolved in 1 mL of acetone and added drop wise to the rapidly stirring
solution. Sodium ascorbate (122 mg, 0.61 mmol) and copper (II) sulfate pentahydrate
(79 mg, 0.32 mmol) were then added, and the resulting dispersion was heated to 100 ºC
for three hours and then lowered to 80 ºC and allowed to proceed overnight. The reaction
mixture was cooled to room temperature, diluted with a saturated NaCl aqueous solution,
and extracted five times with CH2Cl2. The combined organic layers were then dried over
MgSO4 and concentrated by rotary evaporation. The resulting product 6 was dried
overnight under vacuum to yield a yellow viscous liquid in 50-70% yield. GPC (DMF,
after 1 month): Mn = 19,400 g/mol, PDI = 1.07. 1H NMR (CDCl3, 600 MHz):  (CHCl3
= 7.26 ppm) 6.70-7.80 (m, 6 H), 4.73-4.75 (m, 1 H), 4.30-4.32 (m, 2 H), 4.07-4.17 (m, 4
H), 3.64 (tr, J = 6.4 Hz, 2 H), 2.73 (m, 2 H), 2.38-2.60 (m, 6 H), 2.02 (tr, J = 2.5 Hz, 1
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H), 1.64-1.78 (m, 8 H), 1.58 (m, 6 H) ppm. ATR-FTIR: C-H 2944, C-H 2864, C=O 1722
cm-1.
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CHAPTER 3
OLIGOPEPTIDE-FUNCTIONALIZED POLYOLEFINS: SYNTHESIS AND
CHARACTERIZATION OF A MODULAR CLASS OF POLYELECTROLYTES

3.1 Oligopeptide-functionalized Polyolefins as a Modular Class of Polyelectrolyte
Materials
Polyelectrolytes display unique properties as a result of their macromolecular
nature and electrochemical properties. The resulting properties of these materials along
with their widespread applicability in areas such as gene therapy,1-3 tissue engineering,4,5
coatings,6 membranes,7,8 and oil recovery9,10 have drawn physicists, chemists, and
biologists alike to study these materials. Polyelectrolytes display long-range interactions
as a function of their charge density and charge strength, and other parameters such as
backbone flexibility and molecular architecture (hydrogen bonding capability,
hydrophobic forces) also play key roles in the resulting material properties.11
Despite extensive synthetic and characterization efforts, questions remain
concerning the correlation between polymer architecture and the resulting properties.
The lack of this fundamental knowledge is a result of the difficulties in preparing
polyelectrolytes with well-defined architectures and parameters, which can be tuned to
explore a range of polyelectrolyte properties. In response to this need, numerous research
groups have pursued different avenues to achieve well-defined architectures and create
systems with a large degree of modularity.
Conventional polyelectrolytes are typically vinyl polymers (i.e., based on
CH2=CH-X monomers) prepared by anionic12 and free-radical11,13 methods, where the
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charge character is directly on the polymer backbone or on a pendent group. The
negatively or positively-charged X-group is typically in the form of carboxylate,14
ammonium,13,15 sulfonate,16 or pyridinium moieties.17 The close proximity of pendent
charged groups gives rise to steric and charge repulsion that present both synthetic and
characterization challenges. As such, new syntheses that can simultaneously provide
spacing of pendent, charged moieties and thus variable charge density would be
valuable.11 Another challenge with such systems is that they result in different molecular
shapes based upon the ionic strength of the surrounding environment. Therefore, by
eliminating the shape dependence on ionic strength, rigid polymers can provide
information that is difficult to interpret from vinyl-based systems. One example of the
tunability of rigid-rod polyelectrolytes is provided by Wegner and coworkers where they
synthesized sulfonated phenylenes and varied parameters such as charge density to
determine their effect on the resulting material properties.18
Building on the unique properties of polyelectrolytes, branched polyelectrolyte
systems offer the ability to generate a range of structures, from linear polymers to soft
nanoparticles that can be synthesized by controlling the degree of branching. In general,
branched polyelectrolytes with well-defined molecular weights, branching degrees, and
branching type are difficult to synthesize due to lack of functionality tolerance in many
controlled polymerization techniques, making it challenging to elucidate the structureproperty relationships in the resulting materials. Methods such as anionic12, freeradical11,13, macromonomer11, and Suzuki coupling11 based techniques have been
employed to synthesize such architectures and have utilized protection/deprotection
strategies to incorporate various ionic groups. Due to its functional group tolerance,19,20
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metathesis chemistry and ROMP in particular enable the synthesis of wide variety of
olefin-based polyelectrolytes with pendent carboxylate,14,21 ammonium,22 and
oligopeptide23-25 groups. With the introduction of advanced ruthenium catalysts, ROMP
enables the incorporation of carboxylic acids, alcohols, azides, and amides without the
need for protecting groups and only requiring protection strategies for primary amines
and unsaturation.
Herein, unique oligopeptide-functionalized polyelectrolytes based on a polyolefin
backbone are introduced and offer control over parameters such as backbone rigidity,
sign of the charged group, functional group incorporation, and molecular weight. These
polyelectrolytes were synthesized on a multi-gram scale using Fmoc-based SPPS26 for
monomer preparation followed by ROMP (Figure 3-1). In these studies, structureproperty relationships were established by varying charge density (i.e., graft length and
charge spacing) along the polymer backbone and characterizing solution properties by
static and dynamic light scattering. The materials described here contain oligolysine and
poly(ethylene glycol) (PEG) grafts, offering potential for applications in nucleic acid
encapsulation and delivery.
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Figure 3-1. General monomer and polymer synthesis

3.2 Results and Discussion
3.2.1 Synthesis and Characterization of Lysine-containing Monomers
Cyclooctene monomers 7 and 8, containing pentalysine and lysine pendent
groups, respectively, were prepared by Fmoc-based SPPS on a 2-chlorotrityl chloride
resin with loading densities ranging from 1.0-1.4 mol/g.26 Before cleavage from the
resin, the N-terminus of the peptide sequence was capped with 5-carboxylic acid-1cyclooctene.27-29 The oligopeptide-substituted monomers were cleaved from the solid
phase resin under mildly acidic conditions (4:1 dichloromethane:trifluoroethanol
(DCM:TFE)), which enabled removal of the macromonomer from the resin without
cleaving the protecting groups. Monomers 7-9 were characterized by 1H and 13C NMR
spectroscopy, FTIR spectrometry, elemental analysis, mass spectrometry, and/or GPC.
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In the 1H NMR spectra of 7-9, the cyclic olefin protons were seen at ~5.6 ppm. In
addition, GPC traces of macromonomers 7 and 9 showed them to be monomodal and of
very low polydispersity. Due to the affinity of amines for ruthenium, the Boc-protected
forms of 7 and 8 were used for ROMP.

3.2.2 Synthesis and Characterization of Polycyclooctene-graft-lysine 10
Cyclooctene-functionalized monomers 7-9 were polymerized by ROMP using
Grubbs Generation III catalyst ([(H2IMes)(3-Br-pyr)2(Cl)2Ru=CHPh])30 to give the
polymers shown in Figures 3-1 and 3-2 and characterized in Table 3-I. Initial studies
focused on the homopolymerization of 5-pentalysine(Boc)-1-cyclooctene 7. Exploration
of a variety of solvents and temperatures led to optimal polymerization conditions of 0.5
M of 1 in 10/90 DCM/TFE at room temperature for 40 minutes. Under these conditions,
the Boc-protected polymer was obtained in greater than 80% conversion in 40 minutes
and was then purified by precipitation from ether in 80-86% yield. The polymer was
characterized by 1H and 13C NMR. The ring-opening of the cyclic olefin monomer was
confirmed by the 1H NMR spectrum, which showed an upfield shift from 5.6 to 5.2 ppm
in the olefin proton signals. GPC of this Boc-protected polymer was not feasible in THF
or chloroform due to its limited solubility, and a low dn/dc with respect to DMF
prevented reliable GPC characterization in this more polar eluent.
Polycyclooctene-graft-pentalysine(Boc) was deprotected with 4 M HCl in 1,4dioxane and methanol to give 10 (Figure 3-2) as a white powder in 95% yield after
precipitation into acetone. Trace macromonomer was removed by centrifugation using a
filter device (Millipore Amicon Ultra) with a molecular weight cutoff (MWCO) of
10,000 g/mol. 10 was then freeze-dried and characterized by 1H and 13C NMR, GPC,
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Figure 3-2. Oligopeptide-functionalized polyelectrolytes

and static and dynamic light scattering. GPC was performed in 0.5 M aqueous acetic
acid with 0.3 M Na2SO4 using ultraviolet (UV) and refractive index (RI) detection. The
GPC trace of 10 is shown in Figure 3-3, indicating the presence of polymer with
monomodal molecular weight distribution and only trace amounts of macromonomer or
cyclic oligomers. 10, prepared using a 50:1 ratio of Grubbs Generation III catalyst, had a
GPC-estimated number-average molecular weight (Mn) of 87,000 g/mol and a
polydispersity index (PDI) of 1.7 against PEG standards. Given the molecular weight
overestimation expected from GPC on these graft copolymers, the molecular weight
given by GPC is in reasonable agreement with theoretical values (for DP = 50, Mn of the
chloride salt is approximately 49,000 g/mol). However, the solution properties of these
densely-grafted polyelectrolytes in water make light scattering an important
characterization technique as discussed in later sections.
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Figure 3-3. Aqueous GPC chromatograms of deprotected 7 (dashed) and 10 (solid)
in 0.5 M acetic acid, 0.3 M sodium sulfate aqueous buffer at a flow rate of 0.5
mL/min

Compound 2 was sufficiently soluble to carry out the polymerization at a higher
concentration than 1 of 1.2 M in 50/50 DCM/methanol at room temperature. Bocprotected 11 was prepared using a 50:1 monomer:catalyst ratio with Grubbs Generation
III catalyst, and the resulting polymer was amenable to characterization by GPC in THF.
GPC relative to PEG standards on Boc-protected 11 gave Mn and Mw values of 7,500 and
11,000, respectively, with a PDI of 1.5. Using poly(methyl methacrylate) (PMMA)
standards, these values were estimated at 13,000 (Mn) and 18,000 (Mw) with a PDI of 1.4.
At a target DP of 50, the anticipated Mn of 11 was approximately 16,000 g/mol.
Monomer 7 was copolymerized with PEG-functionalized macromonomer 9 (Mn =
1,200 g/mol, Mw = 1,360 g/mol, PDI = 1.09 relative to PEG standards according to THF
GPC), which was prepared by anionic polymerization of ethylene oxide from 5hydroxycyclooctene by Kurt Breitenkamp (Emrick Research Group, Ph.D. 2009). This
ROMP copolymerization to synthesize 12 was catalyzed by Grubbs Generation III
catalyst and proceeded to high conversion in seconds to minutes at ambient temperature.

45

In order to completely solubilize both monomers 7 and 9, the reaction was run at 0.6 M in
50/50 DCM/MeOH. Similar PEG-containing macromonomers are typically polymerized
at higher concentrations to reduce cyclization, but due to the high percentage of solids in
this polymerization, high reaction concentrations were not feasible. A 1:1 feed ratio of
monomers 7 and 9 led to random copolymers composed of approximately 70:30
pentalysine:PEG grafts based on 1H NMR spectroscopy. Before deprotection of the acidlabile Boc group, these pentalysine and PEG-containing graft copolymers were also
characterized by GPC in THF to reveal molecular weights in the range of the targeted DP
of 50, which puts the theoretical Mn around 60,000-65,000 g/mol depending upon the
copolymer composition (PEG standards: Mn = 36,000, Mw = 61,000, PDI = 1.7 and
PMMA standards: Mn = 51,000, Mw = 75,000, PDI = 1.5). At a DP of 50, with a 70:30
pentalysine:PEG ratio of the monomer units, the expected Mn is about 63,000 g/mol.
Boc-protected 12 was deprotected according to the same procedure as 10 and 11 (4 M
HCl in dioxane, methanol, three hours, room temperature). 12 was precipitated into
diethyl ether, isolated in 93% yield as an off-white solid, and characterized by NMR
spectroscopy and GPC. Dynamic and static light scattering were then used to analyze 12
in solution.

46

Table 3-I. Structure and characterization of 10, 11, and 12. All polymerizations
were catalyzed by Grubbs Generation III catalyst using a 50:1 monomer:catalyst
ratio.

3.2.3 Light Scattering Studies of 10, 11, and 12
Static and dynamic light scattering were used to determine the solution properties
of 10-12 (Figure 3-2) as summarized in Table 3-II. Initial studies focused on the effect
of salt concentration and pH on the solution behavior of 10 (Figure 3-4, Table 3-II).
Subsequent experiments focused on the effect of varying the graft length (1 versus 5
lysine groups) by comparing 11 with 10 (Figure 3-5, Table 3-II) and the effect of
increasing charge spacing while maintaining the polymer hydrophilicity using 12 (Figure
3-5, Table 3-II).

3.2.3.1 Light Scattering Studies of 10: The Effect of Ionic Strength
Initial studies focused on the solution behavior of 10 with an emphasis on the
effect of ionic strength and pH. The weight-average molecular weight (Mw), radius of
gyration (Rg), and second viral coefficient (A2) were determined by static light scattering
(SLS) from the generation of Zimm plots for various conditions (Figure 3-4). While the
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pKa of lysine’s side chain amine varies based on its environment (as seen in proteins), it
has a pKa value of around 10 in its free amino acid form.31 As solutions in neutral water,
the oligolysine grafts become protonated. If all the lysine groups release their chloride
counterions when dissolved in water, the observed Mw of 48,000 correlates to a DP of
around 60, in good agreement with the targeted DP of 50. Even after considering that
some counterions will remain associated with the polymer due to counterion
condensation,32,33 dispersion of individual polyelectrolyte molecules is seen in the
concentration range studied. No aggregation of these highly charged, amphiphilic
polymers was seen. The positive second viral coefficient (A2) further indicated this
polyelectrolyte to be in the good solvent regime. An Rg of 25 nm for 10 was measured in
0.1 M NaCl aqueous solution. This measured Rg is considerably larger than the Rg of a
Gaussian chain, calculated to be 6 nm based on a monomer contour length of 1.2 nm and
a degree of polymerization of 60 (based on polymer radius of gyration: Gaussian,
Rg=(1/6)1/2(Llp)1/2; Rod-like, Rg=(1/12)1/2L where L: chain contour length. lp: persistence
length (=1.2nm)). At a fully-extended conformation, the estimated Rg would equal 23
nm. This experimentally-determined Rg of 10 indicates a significantly expanded
conformation in low salt solution.
To investigate the effect of solution ionic strength on polymer conformation, zaverage Mw, A2, and Rg of 10 were measured in 0.5 M NaCl solutions. The decreased A2
value of 10 observed in this environment indicated that the solvent quality became poorer
at elevated ionic strength, and based on the Zimm plot, an Mw value comparable to what
was found in low salt solution was observed at this high salt concentration. The slight
discrepancy seen in the values of Mw at 0.1 M and 0.5 M NaCl can be attributed to the
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standard practice of ignoring salt effects in Zimm plot analysis. The Rg of 10 was
significantly reduced from 25 nm in a 0.1 M NaCl solution to 15 nm in a 0.5 M NaCl
solution.

Figure 3-4. Zimm plot of SLS data (left) and DLS (right) of 10 in 0.1 M aqueous
NaCl at 25oC. Based on DLS, the inverse of relaxation time, 1/, as a function of the
scattering vector squared, q2, is plotted at several concentrations to determine the
hydrodynamic radius Rh of 10.

Figure 3-4 shows the hydrodynamic radius (Rh) measured by dynamic light
scattering for 10 in different polymer concentrations. The linear dependence of inverse
relaxation time on q2 is characteristic of a diffusive motion for 10 in water. It should be
noted that in all of the 10 solutions studied, only one relaxation mode was observed. As
shown in Table 3-II, Rh changed very little (from 11 nm to 10 nm) in a 0.1 M versus 0.5
M NaCl aqueous salt solution, which contrasted the strong salt-dependence of Rg. This
suggested that even though the size of 10 decreased significantly with increasing ionic
strength, its hydrodynamic properties were relatively stable despite the solution changes.
As a measure of chain extension, the Rg/Rh ratio was also calculated at different salt
concentrations. The large Rg/Rh value (~2.3) in 0.1 M NaCl aqueous solution suggests a
highly extended chain conformation, which collapses at higher salt concentration of 0.5

49

Table 3-II. Summary of static and dynamic light scattering studies of 10, 11, and 12

M, as indicated by the lower Rg/Rh (~1.5). Large Rg/Rh ratios have also been observed
for polymers with densely grafted neutral side chains, attributed to the molecules
assuming extended conformations in solution.34-36 The extension of the chain backbone
in a so-called molecular bottlebrush34 originates from a strong excluded volume
interaction caused by crowding side chains, which pushes the otherwise flexible polymer
backbone into an elongated conformation. Analogous to these bottlebrush molecules, 10,
which contain pendent protonated lysines, exhibited an extended conformation due to the
combined effects of steric and electrostatic repulsion of the oligopeptide side chains.
This electrostatic repulsion was significantly screened when the solution ionic strength
was increased from 0.1 to 0.5 M NaCl, as illustrated in the reduced Rg/Rh value in the 0.5
M NaCl solutions. It should also be noted that in high salt solutions, steric crowding
alone from relatively short pendent lysine chains is not sufficient to support an extended
polymer conformation. An extensive computational modeling study is currently being
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undertaken to quantify the relative contributions of steric crowding and electrostatic
interaction on conformational properties of polymers grafted with charged side chains.

3.2.3.2 Light Scattering Studies of 10: pH Effects
10 was seen to assume an extended conformation under conditions at which the
grafts are largely protonated, due to a combination of steric crowding and electrostatic
repulsion of the positively-charged grafts in 0.1 M NaCl solution. Rg and Rh of 10 were
also measured at pH 2 and pH 12 (Table 3-II) (no added NaCl). At pH 2, 10 was
observed to be slightly more extended than at pH 7, a result of lower salt screening
effects. In the high pH environment, the number of protonated amines decreases, and the
grafts become more flexible, resulting in a reduction of Rg and Rh. Unscreened
electrostatic repulsion among residual charges in the grafts is likely responsible for the
conformation that is characterized by a high Rg/Rh ratio at 0.1 M NaCl.

3.2.3.3 Light Scattering Studies of 11
To further explore the effect of the pendent oligolysine grafts on solution
properties, 11 was studied by static and dynamic light scattering in 0.1 M and 0.5 M
NaCl aqueous solutions at neutral pH (Figure 3-5). The Rh of 11 was found to be
extremely small (on the order of 6.5 and 4.4 nm for 0.1 M and 0.5 M NaCl solutions,
respectively). The Rg of 11 in 0.1 M NaCl solution was found to be larger than would be
expected for a globular polymer conformation. The molecular weight indicated
individual polymer chains dispersed in water. Based on Rg/Rh, 11 is viewed as exhibiting
highly anisotropic conformation, which was even greater than the anisotropic behavior
seen in 10. 11 was in a poor solvent regime at high salt concentrations as indicated by
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the negative A2 value measured in 0.5 M NaCl solution. Evaluation of these various
parameters suggests that 11 behaves as a typical hydrophobic polyelectrolyte. Numerous
studies37-41 have determined that when dissolved in water, strongly-charged hydrophobic
polyelectrolytes adopt a “pearl-necklace” conformation in which the polymer chain
consists of multiple mini-aggregates comprised of several monomer units, or “pearls,”
connected by a string of uncollapsed monomers. Due to the repulsion between pearls, the
pearl-necklace conformation becomes stiff. When the solution ionic strength was
increased from 0.1 M to 0.5 M, the electrostatic repulsion among the pearls was screened,
and the entire chain collapsed into a globular structure as evidenced by the decrease in Rg
and Rh. The values of Rg and Rh changed from 27 nm and 6.5 nm at 0.1 M to 9.0 nm and
4.4 nm at 0.5 M NaCl. Although these light scattering results for 11 are consistent with
the pearl-necklace model, more direct observation of “pearls” is desirable. While a direct
observation of pearls formed by a single homopolymer molecule continues to be a
challenge, 11 appears to be an excellent candidate for future experimental verification of
theoretical predictions.

Figure 3-5. Zimm plot of SLS data for 11 (left) and 12 (right) in 0.1 M aqueous NaCl
at 25 oC
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3.2.3.4 Light Scattering Studies of 12
Aqueous solutions of 12 were also studied by light scattering at both low and high
ionic strengths to explore the effect of charge spacing by the introduction of non-ionic,
hydrophilic moieties (Figure 3-5). Compared to 10, the Rg and Rh of the PEGylated
copolymer were substantially higher. Given that the molecular mass of the PEG grafts
are comparable to pentalysine and that the targeted DP of 12 is the same as 10, the
expansion of 12 was unexpected. Incorporating non-ionic, hydrophilic PEG grafts was
expected to reduce the strong electrostatic repulsion among the pentalysine moieties,
which was shown to be responsible for the highly anisotropic conformation of 10.
Therefore, based on the dilution of the electrostatic repulsion, 12 was expected to be
smaller. However, the effective molecular weight of 12 based on light scattering was
measured to be about three times larger than the value obtained by GPC. Furthermore,
the copolymer conformation was stable to drastic changes in ionic strength, in contrast to
the behavior of 10. From these observations, the copolymer chains likely formed
aggregated structures composed of (on average) three chains. One possible origin of such
aggregation could be the hydrophobic nature of the polyolefin backbone. The molecular
origin of why such aggregates are comprised of only a finite number of these copolymer
molecules remains to be fully investigated. The question of the dependence of the
unimer-to-multimer transition on the PEG content is a fundamental problem in
understanding the molecular origin of multimer formation.

3.3 Conclusions
Utilizing a combination of solid phase peptide synthesis and ring-opening
metathesis polymerization, new polyelectrolyte materials were prepared, containing
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hydrophobic backbones with pendent lysine and PEG grafts. These materials were easily
prepared in multi-gram quantities, making them attractive candidates for material-based
applications.
The solution behavior of these polyelectrolytes was tailored by changing the
peptide graft length as well as the spacing of the charged moieties. Despite the flexible
polycyclooctene backbone, polycyclooctene-graft-pentalysine 10 exhibited an extended
conformation in low ionic strength aqueous solutions due to combined influences of
steric crowding and electrostatic repulsion. Screening of electrostatic repulsion at high
ionic strength resulted in a more condensed structure. Pearl-like structures were found
for the monolysine derivative 11 where the hydrophobic backbone collapsed on itself in
the aqueous environment. However, with the introduction of only 30 mole percent PEG
grafts, the resulting random copolymer 12 no longer adopted an extended conformation
based on the Rg and Rh values in solution. Instead, small aggregates with a finite number
of polymer molecules are formed. Various other structural parameters such as negative
versus positive charge and PEG length are currently being studied to better understand
the structure-property relationship of these polyelectrolytes and to explore their potential
in nucleic acid delivery (for the cationic polyelectrolytes) and cartilage mimetics (in the
case of negatively-charged derivatives).

3.4 Experimental Details
3.4.1 Materials
Piperidine (reagent plus, 99%), 2,2,2-trifluoroethanol (TFE) (99.5%),
diisopropylethylamine (biotech grade, 99.5%), methanol (anhydrous, 99.8%), 3-

54

bromopyridine (99%), and Grubbs Generation II catalyst ((1,3-Bis-(2,4,6trimethylphenyl)-2-imidazolidinylidene)
dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium, C46H65Cl2N2PRu) were
purchased from Sigma Aldrich (Saint Louis, MO). N,N-Dimethylformamide (EM
Science, guaranteed reagent, 99.8% and EM Science, anhydrous, 99.8%) and pentane
(EM Science, ACS reagent) were bought from VWR International (West Chester, PA).
Sodium chloride (reagent grade), HCl (concentrated), Millipore Amicon Ultra (MWCO
10,000) centrifugal filter devices, and Millipore hydrophilic PVDF membrane filters
(0.22 mm diameter) were obtained from Thermo Fisher Scientific Inc. (Waltham, MA).
Fmoc-Lys(Boc)-OH, 1-hydroxybenzotriazole (HOBt) hydrate, O-(benzotriazol-1-yl)N,N,N',N'-tetramethyluronium hexafluorophosphate (HBTU), and 2-chlorotrityl chloride
resin (1.4 mmol/g, 100-200 mesh) were purchased from Advanced ChemTech
(Louisville, KY). Deuterated solvents d6-DMSO and D2O were obtained from
Cambridge Isotopes (Andover, MA). CH2Cl2 was washed according to standard
procedures42 and distilled over CaH2. TFE was distilled over sodium bicarbonate.42 All
other materials were used without additional purification.

3.4.2 Instrumentation
NMR spectroscopy was acquired on a Brüker Avance400 (1H) and 100 (13C) MHz
NMR using a Brüker BBO5 probe. Mass spectrometry data were obtained on a JEOL
JMS700 MStation high resolution two-sector mass spectrometer with low resolution
electrospray ionization (ESI). Gel permeation chromatography (GPC) was performed in
tetrahydrofuran (THF) and aqueous eluents. For analysis in THF, a KNAUER HPLC
Pump K-501, UV Detector K-2600 (absorbance measured at 232 nm and 260 nm), and RI
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Detector K-2301 were utilized and equipped with three PLgel 5 mm MIXED-D 300 x 7.5
mm columns (flow rate = 1.0 mL/min). Aqueous GPC was performed in 0.5 M acetic
acid and 0.3 M sodium phosphate buffer with a flow rate of 0.5 mL/min. The aqueous
system was comprised of a HP Series 1050 Pump, HP 1047A RI Detector, and Waters
486 Tunable Absorbance Detector ( = 232 nm) utilizing three Waters Ultrahydrogel
Linear Columns (mixed beads, 7.8 x 300 mm). Elemental analysis (CHN testing) was
performed by Schwarzkopf Microanalytical Laboratory (Woodside, NY). Light
scattering studies were performed with an ALV light scattering apparatus equipped with
an ALV-5000 board. A green laser (COHERENT) with a wavelength of 514.5 nm was
used as light source, and the temperature of the sample holder was held constant at
25+0.1 °C by a circulating water bath.

3.4.3 Synthesis of 5-pentalysine(Boc)-1-cyclooctene (7)

The pentalysine-functionalized macromonomer 7 was synthesized via Fmocbased SPPS with the coupling agent HBTU using a 2-chlorotrityl chloride resin. To load
the resin with the first amino acid unit, the 2-chlorotrityl chloride resin (5.00 g of resin
with 1.40 mmol of functional groups per gram of resin, 7.00 mmol, 100-200 mesh) was
weighed into an oven-dried, glass-fritted reaction tube and swollen with dry DCM (40
mL) for 5-10 minutes. The resin was filtered, and a solution of Fmoc-Lys(Boc)-OH
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(6.56 g, 14.00 mmol), dry DIPEA (6.10 mL, 35.00 mmol), and dry DCM (30-40 mL) was
added to the reaction tube. The tube was capped, vented, and agitated with nitrogen.
After 30 minutes, the resin was filtered and rinsed with dry DMF three times. The
remaining reactive groups on the resin were capped with a 80/15/5 dry
DCM/methanol/DIPEA solution (40 mL, 2 x 10 minutes) and then rinsed with reagent
grade DMF. The Fmoc group was then removed with a 25/75 piperidine/DMF cleavage
solution (2 x 40 mL). The solution was added to the resin, and the resin was agitated for
three minutes. Following filtration, fresh cleavage solution was added and agitated for 20
minutes. The resin was filtered and rinsed with DMF six times, DCM three times,
isopropanol three times, and hexanes six times. The resin was dried by suction filtration
for 15 minutes, transferred to a vial, and dried under vacuum for 24-36 hours. The
loading density was estimated by the change in mass from the starting resin to the final
resin. Loading densities for these syntheses were generally in the range of 0.7-1.4
mmol/g with lower loading densities targeted for longer oligopeptide sequences. To
tailor the degree of functionalization of the resin surface, the number of equivalents of the
amino acid added to the coupling solution was changed. When using 2.00 eq of amino
acid as described above, loading densities generally ranged from 1.20-1.40 mmol per
gram of resin.
Following the addition of the first amino acid residue, the dried resin (6.61 g, 9.25
mmol) was transferred to a dry, glass-fritted reaction tube and swollen with 40 mL of
DCM for five minutes. Fmoc-Lys(Boc)-OH (21.68 g, 46.27 mmol), HOBt (7.09 g, 46.27
mmol), HBTU (17.20 g, 45.34 mmol), and DMF (60 mL, reagent grade) were combined
in an oven-dried round bottom flask, and DIPEA (reagent grade, 16.12 mL, 92.54 mmol)
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was added to form a clear, yellow solution. The activated amino acid solution was then
added to the resin, and the resin was agitated for one hour, filtered, and washed with
DMF three times. As previously described for the resin loading, the Fmoc protecting
group was cleaved with 25/75 piperidine/DMF, after which the resin was washed with
DMF six times. The same procedure was utilized to add lysine units until the desired
oligopeptide sequence length was obtained.
Following the addition of the final lysine residue, the Fmoc protecting group was
cleaved, and the resin was thoroughly washed with DMF. A solution of 5-carboxylic
acid-1-cyclooctene (prepared in three steps from 1,5-cyclooctadiene27-29, 7.14 g, 46.27
mmol), HOBt (7.09 g, 46.27 mmol), HBTU (17.20 g, 45.34 mmol), DIPEA (16.12 mL,
92.54 mmol), and 60 ml of DMF was then added to the resin and agitated from one hour.
The resin was filtered and washed with DMF and DCM three times. The macromonomer
was then cleaved from the resin under mildly acidic conditions (4:1 DCM:TFE). After
45 minutes, the resin was filtered into a clean flask, and fresh solution was added. The
resin was agitated for another 45 minutes, filtered, and washed with 4:1 DCM:TFE and
then DCM three times. This resulting filtrate was concentrated on a rotary evaporator
and then precipitated into diethyl ether. After sitting at 4°C for several hours, the product
was isolated by filtration and then dried under vacuum. The white, powdery product was
obtained in 80-85% yield based upon the estimated loading density and was characterized
by 1H and 13C NMR, ATR-FTIR, low and high resolution mass spectrometry, and
elemental analysis. 1H NMR (d6-DMSO, 400 MHz):  (DMSO = 2.50 ppm) 12.49 (br, 1
H), 7.64-8.03 (br m, 5 H), 6.72 (br, 4 H), 6.40 (br, 1 H), 5.64 (br, 2 H), 4.04-4.30 (br m, 5
H), 2.86 (br, 10 H), 2.22-2.38 (br m, 2 H), 1.97-2.20 (br m, 3 H), 1.10-1.81 (m, 81 H)

58

ppm. 13C NMR (d6-DMSO, 100 MHz):  (DMSO = 39.52 ppm) 177.12, 177.08, 173.42,
171.99, 171.48, 171.41, 171.25, 155.51 (5 C), 129.97, 129.88, 77.31(5 C), 52.70, 52.60,
52.39, 52.21, 51.81, 43.60, 40.35, 32.25, 31.98, 31.81, 31.67 (2 C), 31.22, 30.74, 29.89,
29.57, 29.25 (3 C), 29.14, 28.26 (15 C), 27.49, 27.35, 25.44, 25.37, 24.02, 22.53-22.86
(overlapping, 5 C) ppm. ATR-FTIR: 3282, 2931, 1683, 1630, 1521, 1452, 1392, 1365,
1249, 1169, 864 cm-1. Low resolution ESI (m/z): [M+Na]+ calculated for
NaC64H114N10O17 1317.83, found 1317.8. High resolution FAB (m/z): [M+Na]+
calculated for NaC64H114N10O17 1317.8261, found 1317.8959. Elemental analysis
(CHN): calculated C = 59.33, H = 8.87, N = 10.81, found C = 58.28, H = 8.94, N =
10.44.

3.4.4 Synthesis of 5-monolysine(Boc)-1-cyclooctene (8)

2-chlorotrityl chloride resin was loaded with lysine as previously described.
Following the loading of lysine on the resin, the resin was swollen, and a solution of 5carboxylic acid-1-cyclooctene, HBTU, HOBt, DMF, and DIPEA was added. The resin
was agitated for one hour, filtered, washed with DMF six times, and washed with DCM
three times. 8 was cleaved from the resin as previously described for compound 7, and
the resulting white solid was characterized by 1H and 13C NMR, ATR-FTIR, low and
high resolution mass spectrometry, and elemental analysis. 1H NMR (d6-DMSO, 400

59

MHz):  (DMSO = 2.50 ppm) 12.39 (br, 1 H), 7.80-7.95 (br m, 1 H), 6.77 (br m, 1 H),
6.40 (br s), 5.64 (br m, 2 H), 4.05 (br m, 1 H), 2.86 (br m, 2 H), 2.21-2.38 (br m, 2 H),
1.93-2.21 (m, 3 H), 1.10-1.87 (br, 21 H) ppm. 13C NMR (d6-DMSO, 100 MHz): 
(DMSO = 39.52 ppm) 176.99, 176.91, 174.03, 174.02, 155.63, 130.02, 129.98, 129.95,
77.37, 51.69, 43.58, 43.49, 40.17, 39.96, 39.75, 39.55, 39.34, 39.13, 38.92, 34.26, 32.24,
32.08, 30.67, 29.88, 29.61, 29.17, 28.97, 28.32, 27.61, 27.42, 25.52, 25.46, 24.10, 24.04,
22.97 ppm. ATR-FTIR: 3314, 2929, 2861, 1689, 1646, 1524, 1451, 1392, 1366, 1249,
1166, 988, 861, 778, 712 cm-1. Low resolution ESI (m/z): [M+H]+ calculated for
C20H35N2O5 383.26, found 383.3; [M+Na]+ calculated for NaC20H34N2O5 405.24, found
405.2; [M+K]+ calculated for KC20H34N2O5 421.35, found 421.3. High resolution FAB
(m/z): [M+H]+ calculated for C20H35N2O5 383.2546, found 383.2558. Elemental analysis
(CHN): calculated C = 62.80, H = 8.96, N = 7.32, found C = 62.30, H = 9.02, N = 7.21.
Elemental analysis (CHN): calculated C = 62.80, H = 8.96, N = 7.32, found C = 62.30, H
= 9.02, N = 7.21.

3.4.5 Synthesis of PEG1200-functionalized Macromonomer (9)

In a flame dried air-free flask, 5-hydroxycyclooctene (6.8 mL of a 2.0 M solution
in THF, 13.6 mmol) was added to dry THF (200 mL) while stirring under N2. The
solution was titrated with potassium napthalenide (0.2 M in THF) until a slight green
end-point was observed (~ 70.0 mL). The cyclooctene alkoxide solution was stirred for
an additional 30 minutes at room temperature before being cooled to 0 ºC in an ice/water
bath. Ethylene oxide (15.0 mL, 340.6 mmol) was condensed at -78 ºC using a stainless
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steel gas transfer43 manifold and then slowly warmed to room temperature while
transferring to the cooled cyclooctene alkoxide solution under static vacuum. The
reaction mixture was pressurized with argon, sealed, and stirred at room temperature for
16 hours. The solution was concentrated, and the residue was purified by column
chromatography on silica gel (93/7  90/10 CHCl3/MeOH). The product recovered
from the column was dissolved in a minimal amount of chloroform and precipitated into
a hexane/diethyl ether mixture. A white powder was isolated by filtration and dried
under vacuum to yield 12.5 g (83% yield) of PEG-functionalized macromonomer 9. 1H
NMR (CDCl3, 400 MHz)  (CHCl3 = 7.26 ppm) 5.62 (m, 2 H), 3.28-3.84 (complex, br m,
114 H), 2.54 (br s, 1 H), 1.28-2.36 (complex br m, 11 H) ppm.

13

C NMR (CDCl3, 100

MHz)  (CHCl3 = 77.16 ppm) 130.2, 129.6, 81.1, 72.7, 71.0, 70.7, 70.4, 67.8, 61.8, 34.2,
33.5, 25.9, 25.8, 22.8 ppm. ATR-FTIR: 3491, 2882, 1467, 1359, 1341, 1280, 1242,
1100, 1060, 959, 841, 725 cm-1. GPC (THF, PEG standards): Mn = 1,200 g/mol, Mw =
1,360 g/mol, PDI = 1.09.

3.4.6 Synthesis of Polycyclooctene-graft-pentalysine(Boc) (10 protected).

Polycyclooctene-graft-pentalysine(Boc) (10 protected) was synthesized by
ROMP of 7. Macromonomer 7 (0.88 g, 0.68 mmol) was slowly added to a stirring
solution of dry TFE (1.22 mL). The solution was vortexed until complete dissolution.
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Grubbs Generation III catalyst ([(H2IMes)(3-Br-py)2(Cl)2Ru=CHPh]) was prepared
according to the literature procedure.30 12.0 mg of the catalyst (0.014 mmol, 50:1
monomer:catalyst ratio) was dissolved in dry DCM (136 mL) in a separate vial and
immediately added to the macromonomer solution. The reaction (final concentration 0.5
M 10/90 DCM/TFE) was vortexed for 5-10 minutes, stirred under nitrogen for a total of
40 minutes, and quenched with ethyl vinyl ether (~1 mL). The reaction solution was
precipitated into diethyl ether and isolated by filtration. After drying under vacuum, the
light yellow polymer was obtained in 85% yield and characterized by 1H and 13C NMR.
1

H NMR (d6-DMSO, 400 MHz):  (DMSO = 2.50 ppm) 12.52 (br s, 1 H), 7.60-8.20 (br

m, 5 H), 6.68 (br s, 4 H), 6.38 (br s, 1 H), 5.29 (br s, 2 H), 3.92-4.40 (br m, 5 H), 2.87 (br
s, 10 H), 1.09-2.32 (complex br m, 86 H) ppm.

13

C NMR (d6-DMSO, 100 MHz): 

(DMSO = 39.52 ppm) 173.60, 171.25, 171.00, 155.53, 77.32 (5 C), 51.90-52.10
(overlapping, 2 C), 31.90, 30.80, 29.20, 28.27 (15 C), 22.40-22.60 (overlapping, 5 C)
ppm. Polycyclooctene backbone carbons were not visible by 13C NMR in d6-DMSO.
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3.4.7 Synthesis of Polycyclooctene-graft-pentalysine (10)

Boc-protected 10 (0.512 g, 0.526 mmol) was dissolved in 5 mL of dry methanol,
and excess 4 M HCl in 1,4-dioxane (2 mL) was added. The vented reaction was allowed
to stir at ambient temperature for several hours. The reaction solution was concentrated
and precipitated from acetone. The product was isolated by filtration, rinsed with
acetone, and dried under vacuum overnight, yielding 93% (0.479 g, 0.369 mmol) of the
desired product. Residual macromonomer was removed by centrifugation with filter
devices. The purified polymer was freeze-dried, yielding a white porous solid, and
analyzed by 1H and 13C NMR and aqueous GPC. 1H NMR (D2O, 400 MHz):  (H2O =
4.79 ppm) 5.28-5.62 (br m, 2 H), 4.18-4.42 (m, 5 H), 2.88-3.10 (m, 10 H), 2.36 (br, 1 H),
1.23-1.94 (complex br m, 40 H) ppm.

13

C NMR (D2O + 2 drops d6-DMSO, 100 MHz):

 (DMSO = 39.52 ppm) 180.88, 175.58, 175.35 (2 C), 175.12, 132.48 (2 C), 55.10,
55.02, 54.85, 54.49, 54.35, 40.76, 33.66, 32.14 (5 C), 31.30 (5 C), 27.89 (4 C), 27.79,
23.84, 23.66 (3 C), 23.57 ppm. Some polycyclooctene backbone carbons were not
visible by 13C NMR in D2O/d6-DMSO. GPC (0.5 M acetic acid, 0.3 M Na2SO4 aqueous
buffer): Mn = 87,000 g/mol, Mw = 144,000 g/mol, PDI = 1.7.
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3.4.8 Synthesis of Polycyclooctene-graft-monolysine(Boc) (11 protected)

Similar procedures were utilized to generate the monolysine derivative as used for
the pentalysine analog. The polymerization was performed in 1.2 M 50/50 DCM/MeOH
at room temperature for three hours and was catalyzed by Grubbs Generation III catalyst
(50:1 monomer:catalyst). The resulting polymer was precipitated from diethyl ether,
isolated in 89% yield, and characterized by 1H and 13C NMR and THF GPC. 1H NMR
(d6-DMSO, 400 MHz):  (DMSO = 2.50 ppm) 12.39 (br s, 1 H), 8.72 (br s, 1 H), 7.29
(br m, 1 H), 6.37 (br s), 5.32 (br s, 2 H), 4.15 (br s, 1 H), 2.88 (br s, 2 H), 2.21 (br s, 1 H),
0.9-1.89 (complex br m, 25 H) ppm.

13

C NMR (d6-DMSO, 100 MHz):  (DMSO =

39.52 ppm) 174.89, 173.87, 155.56, 129.91. 129.63, 77.33, 51.53, 45.06, 32.99, 32.68,
32.33, 32.15, 30.53, 30.06, 28.99, 28.46, 28.27, 26.81, 24.78, 22.85 ppm. GPC (THF,
PEG Standards): Mn = 7,500 g/mol, Mw = 11,000, PDI = 1.5. GPC (THF, PMMA
Standards): Mn = 13,000 g/mol, Mw = 18,000, PDI = 1.4.
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3.4.9 Synthesis of Polycyclooctene-graft-monolysine (11).

11 was deprotected according to the same procedure used for 10 and isolated as
an off-white solid in 83% yield. 1H NMR (D2O, 400 MHz):  (H2O = 4.79 ppm) 5.44
(br s, 2 H), 4.39 (br s, 1 H), 3.75 (br m, 3 H), 3.00 (br m, 2 H), 2.40 (br s, 1 H), 1.20-2.15
(complex br m, 16 H) ppm.

13

C NMR (D2O + 2 drops d6-DMSO, 100 MHz):  (DMSO

= 39.52 ppm) 175.72, 131.82, 54.35, 54.02, 47.28, 40.74, 33.63, 31.45, 27.88, 23.99 ppm.
Some polycyclooctene backbone carbons were not visible by 13C NMR in D2O/d6DMSO.
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3.4.10 Synthesis of Polycyclooctene-graft-pentalysine(Boc)-co-polycyclooctene-graftPEG (12 protected)

In a representative polymerization, 7 (0.52 g, 0.40 mmol) and 9 (0.49 g, 0.40
mmol) were copolymerized at room temperature with Grubbs Generation III catalyst
(50:1 monomer:catalyst) in 0.6 M 50/50 DCM/MeOH. The reaction proceeded for three
hours under nitrogen and was quenched with ethyl vinyl ether. The polymer was
precipitated from diethyl ether, isolated by filtration, and freeze-dried. The Bocprotected polymer was isolated in 71% yield as an off-white solid. The resulting material
was analyzed by 1H and 13C NMR and was determined to be composed of 70/30 mole
percent pentalysine(Boc)/PEG1200. The relative molecular weight was estimated by
GPC. 1H NMR (d6-DMSO, 400 MHz):  (DMSO = 2.50 ppm) 12.49 (br s, 1 H), 7.65–
8.14 (br m, 5 H), 6.69 (br s, 5 H), 6.38 (br s), 5.33 (br m, 4 H), 4.55 (br s, 2 H), 4.05-4.38
(br m, 5 H), 3.10-3.79 (complex br m, 114 H), 2.85 (br m, 10 H), 0.98-2.32 (complex br
m, 98 H) ppm.

13

C NMR (d6-DMSO, 100 MHz):  (DMSO = 39.52 ppm) 173.42,

171.50, 171.20, 155.51, 129.94, 77.30 (5 C), 72.35, 70.15, 69.80, 67.51, 60.22, 52.22,
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51.76, 31.83, 30.73, 29.14, 28.26 (15 C), 22.66 (5 C), 22.50 ppm. Some polycyclooctene
backbone carbons were not visible by 13C NMR in d6-DMSO. GPC (THF, PEG
Standards): Mn = 36,000 g/mol, Mw = 61,000, PDI = 1.7.

3.4.11 Synthesis of Polycyclooctene-graft-pentalysine-co-polycyclooctene-graft-PEG
(12).

The Boc-protected copolymer (12 protected) was deprotected and purified using
the same conditions as 10. The final product was an off-white solid and obtained in 93%
yield. 1H NMR (D2O, 400 MHz):  (H2O = 4.79 ppm) 5.44 (br s, 4 H), 4.38 (br s, 5 H),
3.08-3.20 (m, 2 H), 2.85-3.08 (m, 10 H), 1.18-2.52 (complex br m, 53 H) ppm.

13

C NMR

(D2O + 2 drops d6-DMSO, 100 MHz):  (DMSO = 39.52 ppm) 175.67, 175.37 (2 C),
175.15, 73.32, 71.77, 71.15, 61.97, 55.16, 54.51, 40.80, 32.25, 31.37, 27.97, 27.87, 23.72,
23.61 ppm. GPC (0.5 M acetic acid + 0.3 M Na2SO4 aqueous buffer): Mn = 45,000
g/mol, Mw = 91,000, PDI = 2.0.
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3.4.12 Light Scattering Studies: Solution Preparation
NaCl solutions with concentration of 0.1 M and 0.5 M were prepared by
dissolving corresponding amounts of NaCl pellets in water purified by a MilliQ UF
system (Millipore, Billerica, MA) with a resistance of 18.2 . To adjust the pH of a
solution, HCl (diluted from concentrated solution) was used. Stock solutions were
prepared by dissolving the polymer in the NaCl solutions and were then allowed to
equilibrate at room temperature for at least 24 hours prior to further dilution. Light
scattering samples for each polymer were prepared at 3-4 concentrations, ranging from
0.78 to 5.85 g/L. 10 was analyzed at concentrations of 1.46, 2.93, 5.85 g/L (0.1 M NaCl
aqueous solution) and 1.41, 2.83, and 5.65 g/L (0.5 M NaCl aqueous solution). At lower
salt concentrations, 11 was characterized at solution concentrations of 0.78, 1.77, and
3.53 g/L and 1.45, 2.93, and 5.65 g/L for 0.5 M NaCl. Due to its high scattering abilities
at low concentrations, 12 was studied by light scattering at four concentrations: 0.56,
1.12, 2.23, and 4.46 g/L (0.1 M NaCl) and 0.35, 0.80, 1.60, and 3.20 g/L (0.5 M NaCl).

3.4.13 Light Scattering Studies: Static and Dynamic Light Scattering
For static light scattering experiments, the scattering intensity of a toluene
solution was first used as the standard. Sample solutions were directly filtered into precleaned cuvettes by a syringe equipped with a 0.22 μm-diameter membrane filter. Static
light scattering was carried out in the angle range of 35° to 135° with three readings at
each angle. Dn/dc measurements were made on a refractometer and used to calculate
absolute Mw for 10 and 11. In 0.1 M NaCl, the dn/dc values of 10 and 11 were measured
as 0.18 and 0.22. 12 aggregated in solution at the concentration range used to determine
dn/dc, and therefore, its dn/dc in 0.1 M NaCl was estimated as 0.20.
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In dynamic light scattering studies, the scattering intensity autocorrelation, g2(t),
was recorded and analyzed by CONTIN algorithm44 to generate a relaxation spectrum
where a single dominant peak was identified. Its corresponding relaxation time, 1/t, was
then plotted against scattering vector square, q2. The slope of a linear fit of 1/t vs. q2
yielded the diffusion coefficient of 10 at that specific concentration, D(c). The diffusion
coefficient of 10 at zero concentration, D0, was obtained by extrapolating the D(c) vs. c
curve to c = 0 with the relationship of D(c) = D0(1 + kc) where k is a constant. To
determine the hydrodynamic radius Rh, the Stoke-Einstein equation, D0 = kBT/6pRh was
applied where kB is the Boltzmann constant, T represents temperature, and  is the
solvent viscosity at T.

3.5 Future Research
Additional research in the areas of synthesis and characterization can be
envisioned to explore the modularity in this system. Figure 3-6 illustrates additional
macromonomers that have been synthesized and in some cases polymerized. Preparing
these materials and analyzing the correlating solution properties could better explore the
effects of backbone rigidity, cellular targeting groups, negatively-charged amino acids,
different cationic amino acid moieties, and graft length. The final step in the illustrated
design of these amphiphilic graft copolymers (see Figure 4-2) will be to functionalize the
PEG end groups with targeting groups such as RGD or folic acid. Recent work in
conjunction with Kurt Breitenkamp (Emrick Research Group, Ph.D. 2009) has resulted in
the preparation of a PEG-RGD-functionalized macromonomer. Initial attempts at
copolymerizing this macromonomer with other functionalized monomers were successful
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and offer promise for incorporating other biologically-relevant, oligopeptide sequences
into these materials.

Figure 3-6. Oligopeptide-functionalized macromonomers prepared for future
studies
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CHAPTER 4
DNA DELIVERY WITH OLIGOPEPTIDE-FUNCTIONALIZED POLYOLEFINS

4.1 Nucleic Acid Delivery
As effective delivery of nucleic acids is at the core of gene-based therapies,
extensive research has been devoted to determining the effect of structural design on
transfection. In polyplexes, DNA binding affinity, endosomal escape, and
biocompatibility affect the transfection efficiency. The binding affinity of DNA to the
transfection agent impacts its interactions with charged serum proteins, salts, anionic
glycosaminoglycans on cell membrane in the extracellular matrix, and the highly acidic
endosomal environment within the cell. Premature dissociation of the polyplex can result
in reduced cellular entry and/or nucleic acid degradation extracellularly or in the
endosome. Heterocyclic groups such as pyrrole and imidazole have been shown to
strongly bind to DNA due to their ability to specifically hydrogen bond with DNA base
pairs.1-4 Over the past 30 years, Peter Dervan and co-workers have studied these specific
interactions between various polyamides based on pyrrole and imidazole groups and the
minor groove of DNA in an effort to regulate gene expression and offer new therapeutic
options for cancer and other diseases.5-8 Studies of specific interactions using pyrroleand imidazole-based polyamides with the minor groove of DNA provide insight into
polymer-DNA interactions and can aid in the development of cationic transfection
reagents with optimal DNA binding affinity.5-9
These heterocyclic groups along with secondary amines as found in poly(ethylene
imine) (PEI) also aid the polyplexes in escape from the endosomal compartments, one of
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many barriers to nuclear delivery of DNA (Figure 4-1). After achieving cellular entry
via pinocytosis, the polyplexes are trapped within endosomal compartments. The
delivery vehicle must protect the encapsulated DNA due to the low pH found within
these organelles as well as facilitate the polyplex’s release into the cytoplasm.
Incorporating heterocyclic groups and secondary amines into the delivery vehicle buffer
these endosomal compartments by absorbing protons generated by the endosomal proton
pump, slowing the acidification of the organelle. This buffering by the delivery vector
aids in the polyplex release from the endosome into the cytoplasm.10

Figure 4-1. Cellular barriers for DNA delivery to the nucleus

Adjusting electrostatic interactions between the polymer and DNA can increase
polyplex stability. Researchers have demonstrated that the stability of the polyplex, and
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subsequently the effectiveness of the transfection reagent, vary depending on whether
lysine, ornithine, histidine, or arginine is the cationic moiety. 11-13 While polylysineDNA complexes perform transfection, they do so with very low efficiency relative to
reagents such as linear and branched polyethyleneimine PEI10 and polyamidoamine
(PAMAM) dendrimers.14 The recent introduction of branched and dendritic polymers as
transfection reagents provides insight into the role of macromolecular architecture in
transfection efficiency and cytotoxicity.10,14,15 A systematic study of linear versus
branched oligolysine and oligohistidine provides an example of the importance of both
architecture and functionality in plasmid DNA and siRNA complexation and
transfection.12 Branched polymers were found to give smaller polyplexes, while greater
histidine-to-lysine ratios improved protein expression.

4.2 Oligopeptide-functionalized Polyolefins: System Design for Applications in
Nucleic Acid Delivery
Polyolefin-graft-oligopeptide structures were prepared and tested experimentally
for their utility in nucleic acid delivery. The concept, illustrated in Figure 4-2, consists
of an amphiphilic graft copolymer containing a hydrophobic backbone with a
hydrophilic, charged graft structure. The simplest amphiphilic graft system consists of a
homopolymer with cationic grafts, which will enable the study of nucleic acid
encapsulation resulting from the electrostatic interactions between a cationic polymer and
negatively-charged plasmid DNA or RNA. PEG grafts, shown as the second example,
are dispersed among the cationic grafts to enhance the biocompatibility and
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Figure 4-2. Design of oligopeptide-functionalized polyolefin materials for
applications in nucleic acid delivery

protein-resistance of the encapsulated system. The PEG-corona, expected to form in
water, will shield the encapsulated nucleic acid from enzymatic degradation in vivo and
prevent protein adsorption during systemic circulation. In a more advanced system, the
PEG grafts incorporated into the copolymer could be end-capped with targeting groups
that may enable cell-specific delivery.
Utilization of the graft copolymer structure enables control of numerous system
parameters that cannot be obtained from linear polymers including:
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Control over Charge Density – By controlling the length of the cationic amino
acid grafts, as well as the amount incorporated into the polymer backbone, the degree of
excess cationic charge can be controlled. This may prevent the cytotoxicity levels seen in
PEI, a current standard in polymeric, non-viral delivery systems.10
Incorporation of Non-immunogenic, Protective Groups – PEG is frequently
used in biomedical applications due to its biocompatibility and non-immunogenicity.16
By incorporating PEG grafts, a protective, non-immunogenic outer corona can protect the
particle exterior of the encapsulated DNA and reduce non-specific interactions and
protein adsorption during circulation.
Based upon these design principles, research focused on the preparation of
hydrolytically stable polyolefins with cationic amino acid grafts via ROMP (Figure 4-3).
The syntheses and characterization of these materials have been described already in
Chapter 3. Nonionic, hydrophilic PEG grafts were incorporated into copolymer
structures by copolymerization of PEG-functionalized cyclooctene macromonomers. To
evaluate the role of architecture in transfection, these amphiphilic graft copolymers were
compared with linear polylysine (PLL) and commercial transfection reagents with respect
to protein expression and cell viability following transfection.

4.3 Results and Discussion
4.3.1 Materials
Amphiphilic graft copolymers, consisting of a hydrophobic polycyclooctene
backbone decorated with pendent oligolysines, were evaluated for their ability to
facilitate DNA transfection into cells. ROMP of Boc-protected lysine and PEG-
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substituted cyclooctenes gave polymers 10 and 12 as shown in Figure 4-3. In polymer
10, prepared by ROMP of the Boc-protected 5-pentalysine-1-cyclooctene macromonomer
7, the pentalysine grafts are placed on average at every eighth backbone carbon atom.
The salt of macromonomer 7 was used in transfection experiments for comparative
purposes. Polymer 12 integrates PEG grafts into the structure by copolymerization with a
PEG1200-substituted cyclooctene macromonomer to reduce the charge density but
maintain water solubility. The solid phase peptide synthesis of macromonomer 7 and the
syntheses of polymers 10 and 12 are described in detail in Chapter 3.19

Figure 4-3. Polymers used in polyplex formation and transfection
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4.3.2 Complexation
Polymer 10 was first studied for its ability to complex plasmid DNA. Nucleasefree aqueous polymer solutions were added to DNA solutions at various N:P ratios (i.e.,
the ratio of protonatable nitrogens in the polymer (N) to DNA phosphates (P)). Thirty
minutes after mixing, the solutions were analyzed by agarose gel electrophoresis (0.8
weight percent with ethidium bromide). For polymer 10, complete DNA complexation
was obtained at N:P > 2 as indicated by the absence of free DNA bands at these ratios as
shown in Figure 4-4 (representative data for polymer 10e shown). Dynamic light
scattering was used to evaluate the hydrodynamic size of the polymer-DNA complexes.
As shown in Figure 4-4, polyplexes formed by complexation of plasmid DNA and
polymer 10e are ~80 nm diameter particles with relatively low size distribution. These
polyplexes were found to very stable over a 24-hour timeframe in water; no aggregation
or size change was observed by light scattering.

Figure 4-4. Polyplex characterization: a) gel electrophoresis and b) dynamic light
scattering of polymer 10e-DNA complexes
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4.3.3 Cell Transfection Studies
Initial transfection experiments were performed with COS-1 cells obtained from
the Schwartz Research Group (University of Massachusetts Department of Biology).
Polymers 10 and 12 of the various molecular weights given in Figure 4-3 were
complexed with the GFP-expressing reporter vector pZsGreen1-N1 and were analyzed 48
hours post-transfection using a plate reader, fluorescence microscope, and the CellTiterGlo Luminescent cell viability assay. For comparison, commercial transfection
reagents jetPEI (PolyPlus Transfection), Lipofectamine 2000 (Invitrogen), and
SuperFect (Qiagen) were also used for COS-1 transfection according to the optimized
protocols supplied by the manufacturers.
Cells transfected with polyplexes containing polymers 10b-e at their optimal N:P
ratios demonstrated substantial protein expression and typically higher cell viability than
those treated with the commercial reagents (Figure 4-5). The degree of polymerization
(DP) of 10 appeared to be important with increasing average DPs of 63, 75, 89, and 206
(polymers 10b, c, d, and e, respectively) providing better transfection efficiency than the
lower molecular weight polymer 10a. It is believed that the stability of the polyplexes
increases with increasing molecular weight, which results in greater protein expression as
seen with these materials. Polyplexes using 10a (DP 30) gave very little protein
expression as judged by fluorescence microscopy. In contrast, the highest molecular
weight derivative polymer 10e (DP 206) showed greater overall gene expression than
commercial transfection reagents jetPEIand SuperFect and lower expression than
Lipofectamine 2000, while maintaining excellent cell viability. Increased cytotoxicity
with higher molecular weight polymer derivatives was not observed as 10e at the optimal
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N:P for transfection still maintained 99% cell viability in COS-1 cells. However,
increased toxicity was observed at higher N:P as in the case of 10b. In order to obtain
significant protein expression with this material, an N:P ratio of 4 was required but
resulted in only 77% cell viability. Polymers 10b, c, and d also facilitated DNA
transfection as indicated by protein expression levels but with lower effectiveness than
10e.

Figure 4-5. Relative fluorescence (left) and cell viability (right) of COS-1 cells
treated with polymers 10a-e at their optimal N:P ratio for protein expression.
Fluorescence was measured 48 hours post-transfection (plate reader filters  exc =
485 nm,  em = 520 nm).
When evaluated at comparable N:P ratios as polymer 10, pentalysine
macromonomer 7 proved unsuitable for transfection (Figure 4-6). This is in agreement
with reports by Szoka and coworkers on poor transfection performance with polyplexes
formed from short oligolysine segments, which require substantially higher N:P ratios to
effectively complex DNA.11 However, when 7 was polymerized to form amphiphilic
graft copolymer 10, the resulting material behaved much differently, thus demonstrating
the benefit of the multidentate interactions inherent to macromolecules and, in this case,
the graft or comb-like structure designed to facilitate such interactions.
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Linear PLLs, containing on average 126, 219, and 262 lysine repeat units, were
also analyzed in COS-1 transfection experiments. Despite having a similar overall
number of protonatable nitrogens as polymers 10a-c, which had on average 120, 254, and
301 protonatable nitrogens per polymer chain, these linear polymers gave low
transfection efficiency. The highest molecular weight PLL (DP 262) showed the best
transfection (Figure 4-6) but was still inferior to polymer 10 derivatives and the
commercial reagents. The differing abilities of PLL versus polymer 10 as transfection
reagents might be attributed to the role of macromolecular architecture (linear versus
graft structure), as well as the amphiphilic nature of 10 with its hydrophobic backbone
and hydrophilic oligolysine grafts. Amphiphilic molecules such as fusogenic peptides are
known to preferentially segregate to cell membranes and aid in cellular entry.
The PEG-containing cationic graft copolymers of type 12 were found to be
inferior transfection vehicles relative to 10 in accord with literature reports on PEGylated
cationic polymer transfection reagents.20-23 This might be attributed to several factors
including molecular weight (12 had an average DP of only 35) as well as poorer
complexation due to a combination of increased steric hindrance and reduced charge
density. Also, the presence of the PEG grafts may shield charge on the surface of the
polyplexes, reducing cellular entry and protein expression. Although adding the PEG
segments reduces the transfection in vitro, the incorporation of such groups would be
advantageous in vivo for systemic delivery applications since PEG chains prevent nonspecific protein adsorption. Therefore, future efforts should focus on evaluating higher
molecular weight derivatives of polymer 12 and determining the optimal PEG-topentalysine graft ratio to maximize transfection efficiency for these structures.
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Figure 4-6. Relative fluorescence (left) and cell viability (right) of COS-1 cells
treated with polymer 10e, polymer 12, salt of macromonomer 7, linear PLL (DP
262), and commercial reagents jetPEI, SuperFect, and Lipofectamine 2000.
Fluorescence was measured 48 hours post-transfection (plate reader filters  exc =
485 nm,  em = 520 nm).
With HeLa cells, which are more difficult to transfect and more sensitive to
toxicity than COS-1 cells, polymer 10e-based polyplexes competed favorably with all
three commercial reagents. This is seen qualitatively in the fluorescence microscope
images of the transfected cells in Figure 4-7. When polymer 10e served as the
transfection reagent, little change in the cell morphology was observed, indicating
minimal alteration to cell growth and minimal cytotoxicity. This contrasts the
fluorescence images obtained in experiments with jetPEI, SuperFect, and
Lipofectamine 2000, in which significant morphological alterations and substantial cell
death was observed. Figure 4-8 provides a quantitative comparison of 10e-containing
polyplexes with commercial reagents in terms of GFP expression and cell viability. Even
relative to Lipofectamine 2000, which out-performed all polymer 10 derivatives in the
COS-1 experiments, 10e proved to be an excellent transfection reagent (relative
fluorescence units for Lipofectamine 2000 = 12,000 versus 19,000 for polymer 10e)
while maintaining high levels of cell viability (17% for Lipofectamine 2000 versus
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92% for polymer 10e). Synthetic polymer delivery vectors are known to be less toxic
than lipid-based and other systems, but they typically do not reach comparable protein
expression levels. However, 10e was found to be extraordinarily effective in facilitating
DNA delivery while still maintaining excellent cell viability. The appeal of amphiphilic
graft copolymer 10e as a transfection reagent can be attributed to its balance of
transfection efficiency and biocompatibility, a balance which becomes increasingly
important in vitro for sensitive cell lines as well as in vivo for systemic delivery.

Figure 4-7. Fluorescence microscope images ( exc = 467-497 nm,  em = 516-556 nm)
of HeLa cells transfected with complexes of pZsGreen1-N1 (GFP-expressing
plasmid DNA) and various transfection reagents: polymer 10e (N:P 3), jetPEI,
Superfect, and Lipofectamine 2000.
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Figure 4-8. Relative fluorescence (left) and cell viability (right) of HeLa cells
transfected with polymer 10e (N:P 3) and commercial reagents jetPEI, SuperFect,
and Lipofectamine 2000. Fluorescence was measured relative to positive controls
48 hours post-transfection (plate reader filters  exc = 485 nm,  em = 520 nm).
Deprotected macromonomer 5-pentalysine-1-cyclooctene 7, polymer 12, and
polylysine were ineffective transfection reagents in HeLa cells (data not shown).

The experiments described indicate that the use of polymer 10e as a DNA
delivery vector requires attention to multiple factors including the delivery vehicle’s
molecular weight, amphiphilic nature, and architecture. Polymer molecular weight is
known to influence transfection performance as seen for polymers 10a-10e and other
reported systems.24-27 The high molecular weight of 10e also provides additional
stabilization to the polyplexes, preventing premature DNA release and subsequent DNA
degradation.28 Studies by Schaffer, et al. with PLL derivatives (DP 19, 36, and 180)
demonstrate that intermediate molecular weight polymers are optimal delivery vehicles
since they balance the need for polyplex stability with the requirement of eventual
polyplex dissociation.25 In the case of high molecular weight PLL with a DP ~180, the
DNA was unable to dissociate from the delivery vector, preventing eventual protein
expression. However, in our studies with the molecular weight series for polymer 10, a
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substantial increase in protein expression was observed with the highest molecular weight
derivative 10e (DP ~206). This implies that despite the large DP of 10e, which provides
stability for the polymer-DNA complex, other features of this graft copolymer facilitate
DNA release from the polyplex once it is within the cell. Intracellular trafficking studies
will be reported in the future to better elucidate this structure-property relationship.
Emrick Group Members Drs. Delphine Chan-Seng and Sangram Parelkar are currently
conducting these studies.
Moreover, we note that amphiphilicity is characteristic of naturally-occurring
fusogenic peptide segments, which are known to aid proteins in cellular entry and
endosomal escape by membrane interactions.29 Because 10e contains both hydrophobic
and hydrophilic domains, this polymer vector may enhance cellular entry and endosomal
escape in a manner similar to fusogenic peptides. In addition, the hydrophobic backbone
of 10e may interact with the hydrophobic domains of DNA, further stabilizing the
polyplex.
The comb-like architecture of 10e must also be considered when determining the
structural features which contribute to delivery efficiency. Pentalysine grafts are present
on average at every eighth carbon atom, and because of the close proximity of the lysines
within the graft and along the polymer backbone, it is likely that incomplete protonation
is achieved. Studies by Suh et al. with PEI, hydrophobically-modified PEI, and
polyallylamine show that the protonation of an amine in a multiamine-containing
compound suppresses additional protonation events.30 They also determined that
hydrophobic environments make protonation unfavorable. Therefore, we speculate that
in 10e the close proximity of the lysine groups, as well as that of the grafts to the
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hydrophobic backbone, prevent complete protonation of the oligolysine chains at neutral
pH, thus offering a buffering mechanism that might aid in endosomal escape in vitro.

4.4 Conclusions and Future Research
This chapter described a novel and effective transfection reagent based upon an
amphiphilic, cationic, comb-like polyelectrolyte. These polyplexes effectively transfect
COS-1 and HeLa cell lines, while maintaining high cell viability. These reagents are
clearly competitive with commercial polymer-, dendrimer-, and lipid-based transfection
reagents in terms of both protein expression and cell viability, and as such open
possibilities for new transfection reagent choices among the biomaterials and gene
delivery communities. To further elucidate the structure-property relationship of these
materials, several future experiments could be envisioned with respect to oligolysine graft
length, molecular weight, and copolymer composition. While pentalysine derivatives
were evaluated, expanding the range of oligolysine graft lengths is important as a next set
of experiments. While a range of graft copolymer molecular weights were investigated in
these experiments, it is not yet known whether the optimal molecular weight polymers
were used. Additional experiments to determine the ideal molecular weight for DNA
delivery might lead to such optimization. Further investigation would also be beneficial
in the area of copolymer composition. While initial investigations showed the polymer 2
offered significantly reduced transfection compared to polymer 1, it is important to
incorporate PEG grafts for in vivo applications. Therefore, additional research exploring
the role of molecular weight as well as copolymer composition (i.e., ratio of
pentalysine:PEG grafts) on transfection efficiency may provide transfection reagents
useful in in vivo applications.
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4.5 Experimental
4.5.1 Materials
COS-1 (African green monkey kidney cells, Cercopithecus aethiops) and HeLa
(human adenocarcinoma epithelial cervical cells) cell lines were purchased from
American Type Cell Culture (ATCC, Manassas, VA) or donated by the Schwartz
Research Group (University of Massachusetts, Department of Biology). Dulbecco’s
Modified Eagle Medium (DMEM), fetal bovine serum (FBS), penicillin, streptomycin,
sodium pyruvate, and Lipofectamine 2000 were purchased from Invitrogen
Corporation (Carlsbad, CA). Agarose (molecular biology grade, low-EEO), ethidium
bromide (1% solution, molecular biology grade), tris-acetate-EDTA (TAE) buffer (10x
solution, electrophoresis grade), agarose gel-loading dye (6x, contains 15% Ficoll 400,
molecular biology grade), Costar white-walled 96-well plates, Nalgene PES syringe
filters (0.2 m, 13 mm diameter), and low retention Eppendorf tubes were purchased
from Thermo Fisher Scientific (Waltham, MA). Poly-L-lysine hydrobromide was
obtained from Sigma-Aldrich (Saint Louis, MO). CellGro Eagle’s Minimum Essential
Medium, trypsin with EDTA, and non-natural amino acid supplements were purchased
from Mediatech, Inc. (Herndon, VA). Gel loading dye was purchased from Biorad
(Hercules, CA). jetPEI was received from PolyPlus Transfection (San Marcos, CA).
EndoFree Plasmid Maxi Kit and SuperFect Transfection Reagent were obtained from
Qiagen (Valencia, CA). DH5 cells were donated by Jeff Kane and Professor Larry
Schwartz (University of Massachusetts, Department of Biology). Nuclease-free water
and CellTiter-Glo Luminescent Cell Viability Assay were obtained from Promega
Corporation (Madison, WI).
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Prior to the encapsulation and cell transfection experiments, the reporter gene
pZsGreen1-N1, a GFP-expressing plasmid with 4,700 base pairs, was purchased from
Clontech (Mountain View, CA) and then amplified and purified. DH5 cells,
Escherichia coli cells, which had been prepared for transformation, were used as hosts
for bacterial transformation according to standard molecular biology procedures.31 The
amplified DNA was isolated and purified with a EndoFree Plasmid Maxi Purification kit.
UV analysis (Pharmacia Biotech GeneQuant II) was used to determine the concentration
and purity (260/280 ratio) of the amplified DNA stock solution prepared by bacterial
transformation.

4.5.2 Gel Electrophoresis
Agarose (0.48 g) was added to 1x TAE buffer (60 mL) to prepare a 0.8 weight
percent agarose gel. The solution was heated until boiling and apparent dissolution.
After cooling for five minutes, 3 μL of 1 weight percent ethidium bromide solution was
added to the agarose solution. This mixture was poured into a gel cassette containing a
10-well comb and allowed to set for 30 minutes.
To prepare the polyplex solutions, 1 μg of DNA was diluted in nuclease-free
water to obtain a final volume of 10 μL. Separately, polymer solutions of various
concentrations were prepared. 10 μL of each polymer solution was added to the DNA
solution and allowed to equilibrate for 30 minutes. 2 μL of nucleic acid loading buffer
was mixed with the polyplex solution, and 18 μL of the final solution was loaded onto the
gel. The gel was run using a FisherBiotech horizontal minigel (7 x 10 cm) setup and an
Invitrogen PowerEase500 power supply at 60 volts for 60-90 minutes in 1x TAE buffer.
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The gel was then imaged with a Spectroline Slimline UV transilluminator equipped with
a Canon Powershot A620 camera.

4.5.3 Dynamic Light Scattering
Polyplexes were prepared in filtered, nuclease-free water in a black-walled 96well plate with a total well volume of 100 μl each. Prior to analyses, the plate was
centrifuged at 1,000 rotations per minute for 2 minutes to remove excess air bubbles.
The plate was inserted into a Wyatt DynaPro Plate Reader equipped with a temperature
control module (set to analyze at 37 °C) and allowed to equilibrate for 10 minutes.
Acquisition time was set to 60 seconds, and three runs were performed in each well,
which were averaged together. The wells were analyzed every six hours over a 24-hour
period.

4.5.4 Cell Culturing
COS-1 and HeLa cells were cultured according to standard protocol32 and utilized
for cell transfection experiments.

4.5.5 Cell Transfection
COS-1 and HeLa cells were cultured according to standard protocol, and low
passage number cells (less than 20) were used for cell transfection experiments. COS-1
and HeLa cells were plated in white-walled 96-well plates at seeding densities of 7 x 103
cells per well and incubated in 5% CO2 at 37 ºC 24 hours prior to transfection. After 24
hours, the cells were 70-80% confluent and were transfected as described below.
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The polymers and macromonomer (1-2 mg) were weighed into low retention
Eppendorf tubes, dissolved in nuclease-free water, and sterilized by filtration. The stock
solutions were diluted to the appropriate concentrations to enable complexation with
DNA at various N:P ratios. DNA solutions (4x solution for each polymer concentration)
were prepared in a 96-deep well plate. DNA (1 μg) was added to nuclease-free water (40
μL). 40 μL of the diluted polymer solutions were added to the DNA solutions and
allowed to equilibrate for a minimum of 30 minutes. Prior to transfection, the cells were
washed with serum-free media. The polyplexes were diluted with 120 μL serum-free
media (DMEM for COS-1 cells, MEM for HeLa cells), and 60 μL of the diluted polyplex
solution was added directly to the cells. Each condition was repeated in triplicate.
Commercial reagents PLL, jetPEI, SuperFect, and Lipofectamine 2000 were also
used as transfection reagents according to each manufacturer’s recommended protocol.
After 4 hours of incubation at 5% CO2 and 37 ºC, 120 μL of serum-containing
growth media (10% fetal bovine serum, 1% penicillin/streptomycin, 1% sodium
pyruvate, and 1% non-natural amino acids) was added to each well. The cell media was
replaced with 150 μL of fresh serum-containing growth media 24 hours after transfection,
and the cells were analyzed after 48 hours by fluorescence microscopy (Olympus IX71
fluorescence inverted microscope equipped with an Olympus DP71 digital camera), by
plate reader in fluorescence mode (BMG Labtech FLUOstar OPTIMA plate reader) and
by the CellTiter-Glo Luminescent Cell Viability Assay. Transfection data shown in
Figures 4-5, 4-6, and 4-8 are averaged values obtained over multiple experiments. In
each experiment, each unique condition (i.e., different polymer, N:P ratio, etc.) was
tested in triplicate.
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4.5.6 Cell Viability Assay
To determine cell viability 48 hours after transfection, Promega’s CellTiter-Glo
Luminescent Cell Viability Assay was performed according to the recommended
commercial protocol. The CellTiter-Glo buffer and substrate were equilibrated to room
temperature, and the buffer was added to the substrate to form the CellTiter-Glo
reagent. After equilibrating the 96-well plate to room temperature, the cell media was
replaced with 70 μL of serum-free media, and 70 μL of the mixed CellTiter-Glo
reagent was added to each well. The plate was mixed on an orbital shaker for 2 minutes
and then allowed to sit for 10-20 minutes. Luminescence was recorded on a plate reader
(BMG Labtech FLUOstar OPTIMA plate reader). The average luminescence values for
each condition were divided by the average luminescence of the control cells (cells
treated with media only) to determine the percent cell viability. As with the transfection
data, cell viability results shown in Figures 4-5, 4-6, and 4-8 are averaged values
obtained over multiple experiments. In each experiment, each unique condition (i.e.,
different polymer, N:P ratio, etc.) was tested in triplicate.
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CHAPTER 5
FUTURE STUDIES

5.1 Oligopeptide-functionalized Polyesters
Click chemistry was successfully used to graft oligopeptide sequences onto
hydrolytically degradable polyester backbones. To demonstrate the versatility of this
technique, the conjugation of various other oligopeptide sequences to the polyester
backbone could prove interesting. One proposed study would focus on using click
chemistry to conjugate cationic oligopeptides to aliphatic polyesters for applications in
nucleic acid delivery. While the polyolefin-graft-pentalysine system described in
Chapters 3-4 offers a hydrolytically stable, robust backbone that can be used to
encapsulate plasmid DNA, a polyester-graft-pentalysine (or other cationic amino acid)
generates a polymeric encapsulation system that is degradable. Azide-functionalized triand pentalysine and pentaarginine sequences were prepared by solid phase peptide
synthesis according to the same synthetic techniques previously described for SDGRG.
Initial experiments were performed to determine if the trilysine-azide sequences could be
clicked to the polyester backbone without significant degradation. Several reaction
conditions were investigated, but additional experiments are necessary to determine
whether click chemistry is a viable route for introducing cationic functionalities to
polyesters. In a similar approach to the polyolefin system described in Chapters 3-4,
variations in the polymer structure could be explored in future studies for such
applications including the incorporation of other cationic sequences (lysine versus
arginine) and PEG groups in conjunction with the peptide grafts.
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5.2 Oligopeptide-functionalized Polyolefins as Novel Polyelectrolytes
To further explore these materials as novel polyelectrolytes, future synthetic
efforts should focus on incorporating structural variations such as negatively-charged
moieties and increased backbone rigidity. Along these lines, my synthetic efforts focused
on varying the cyclic olefin and the charged moiety incorporated into the
macromonomer. Norbornene-graft-pentalysine(Boc) was prepared via SPPS by capping
the N-terminus of the oligopeptide sequence with commercially-available 5-norbornene2-carboxylic acid. Cyclooctene-graft-penta(aspartic acid) was synthesized with and
without butyl(But)-protecting groups according to a similar procedure as 7 and standard
Fmoc-SPPS techniques. The enhanced solubility contributed by the tert-butyl protecting
groups made the protected derivative easier to purify and polymerize and was used for
preparing the negatively-charged polyelectrolyte materials. Upon GPC analysis of
poly(cyclooctene-graft-penta(aspartic acid)(OBut)), it was found that unlike the
polymerization of 7, the aspartic acid-containing macromonomer had to be polymerized
at a concentration of 1 M or above and at room temperature to prevent the formation of
low molecular weight cyclics. When the polymerization was carried at elevated
temperatures (40 °C and above) or at a concentration of 0.5 M, cyclics were observed in
the GPC chromatogram. While both the norbornene- and aspartic acid-containing
macromonomers were synthesized and polymerized, polymerization, deprotection, and
purification conditions were not optimized, and the resulting polymers’ solution
properties were not studied. Future efforts along these lines may provide valuable
information on the range of polyelectrolytes that can be prepared in this class of
materials.
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Additional synthetic modifications can be incorporated to allow the PEG end
groups to be functionalized with targeting groups such as folate and a RGD oligopeptide
sequence. These groups have previously been incorporated into gene delivery systems to
enable cell-specific interactions and selective cellular entry and can be incorporated as
PEG end groups.17,18 Initial studies in this area were performed with Kurt Breitenkamp,
Ph.D. (Emrick Research Group, Ph.D. 2009). An RGD-containing oligopeptide was
prepared by SPPS and coupled with cyclooctene-PEG-carboxylic acid on the resin. The
resulting compound was cleaved from the resin under mildly acid conditions, isolated,
and characterized. Analyses by NMR, GPC, and MALDI support the synthesis of the
desired cyclooctene-PEG-RGD macromonomer. Future synthetic efforts should focus on
copolymerizing this macromonomer with other oligopeptide-functionalized
macromonomers to create an array of materials with cell-targeting abilities.

5.3 Oligopeptide-functionalized Polyolefins for Nucleic Acid Delivery
To further explore the structure-property relationship of oligopeptidefunctionalized polyolefins as nucleic acid delivery vectors, future experiments
determining the role of oligolysine graft length, molecular weight, copolymer
composition, the cationic group (e.g., lysine versus arginine), and incorporation of
histidine groups to aid in endosomal escape may prove interesting. Ongoing efforts in
the Emrick Research Group by Drs. Delphine Chan-Seng and Sangram Parelkar are
focused on comparing the transfection efficiency and cytotoxicity of polycyclooctene
derivatives containing 3, 4, and 5 lysine moieties per repeat unit as well as the
determining the optimal molecular weight. The research described in this thesis showed
preliminarily the effect of PEG moieties on the resulting copolymer’s transfection
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properties. However, additional studies are needed to determine what the optimal
cationic:PEG ratio is for both in vitro and in vivo applications.
Since the polyolefin materials were designed to encapsulate various nucleic acids,
the application of these materials in siRNA delivery should also be explored. Preliminary
experiments demonstrated successful siRNA encapsulation and in vitro gene knockdown
with these oligopeptide-functionalized polyolefin delivery vectors. Due to the potential
impact of siRNA therapeutics in treating such diseases as cancer and HIV, additional
studies are warranted and may provide valuable insight on designing effective siRNA
delivery vehicles.

.
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